ESPE Abstracts

Contents

• Plenary Lectures
• • Environmental chemicals, brain development and human intelligence
  • • Environmental Chemicals, Thyroid Hormone and Human Intelligence

      hrp0086pl1
  • Recent stories on the genetics of adrenal hyperfunction and tumors
  • • Recent Advances in the Genetics of Adrenal Hyperfunction and Tumours

      hrp0086pl2
  • Calcium-sensing receptor signalling in physiology and diseases
  • • Abstract unavailable

      hrp0086pl3
  • Genomic imprinting and evolution
  • • [ldquo]Genomic Imprinting and Evolution[rdquo]

      hrp0086pl4
  • Genetics of common and uncommon obesity
  • • Abstract unavailable

      hrp0086pl5
  • Cell therapy in Type 1 diabetes - ISPAD
  • • Abstract unavailable

      hrp0086pl6
• Symposia
• • Innovative therapies in bone and mineral metabolism
  • • Innovative Therapies in Bone and Mineral Metabolism: Anti FGF23 in X-linked Hypophosphatemia

      hrp0086s1.1
    • [ldquo]Denosumab as an Alternative to Bisphosphonates in Osteogenesis Imperfecta[rdquo]

      hrp0086s1.2
    • Advances in Treatment of Achondroplasia

      hrp0086s1.3
  • Genetics and epigenetics of thyroid dysgenesis
  • • Determination of Autosomal Monoallelic Expression in Thyroid Tissue Assessed by Whole-Exome and Bulk RNA Sequencing: A Role in Thyroid Dysgenesis, Autoimmunity and Cancer

      hrp0086s2.1
    • Genetics of Thyroid Dysgenesis and Associated Malformations

      hrp0086s2.2
    • New Insights in Thyroid Development

      hrp0086s2.3
  • Optimizing nocturnal diabetes control
  • • Sleep and Glycaemic Control in Children with Type 1 Diabetes

      hrp0086s3.1
    • Optimising Nocturnal Glucose Control in Children with T1D: Therapeutic Implications

      hrp0086s3.2
    • Optimizing Nocturnal Diabetes Control: Optimising Insulin Delivery with New Technology: But Where is the Evidence?

      hrp0086s3.3
  • New avenues in paediatric autoimmune disease
  • • Activating Mutations in STAT3 Leading to Early-Onset Multi-organ Autoimmune Disease

      hrp0086s4.1
    • Abstract unavailable

      hrp0086s4.2
    • Type 1 Diabetes: Lessons from nPOD Pathology and Clinical Trials

      hrp0086s4.3
  • Mitochondrial dysfunction and endoplasmic reticulum stress in endocrine diseases
  • • Wolfram Syndrome, a Prototype of ER Stress-Induced Beta Cell Death

      hrp0086s5.1
    • Abstract unavailable

      hrp0086s5.2
    • Activation of HSP 72: A Therapeutic Target for Diseases Related to both ER Stress and Mitochondrial Dysfunction

      hrp0086s5.3
  • Prevention of childhood obesity
  • • Long-term Consequences of Childhood Obesity: The Impact of Genes and Lifestyle

      hrp0086s6.1
    • Early Childhood Life Style Intervention and Obesity Outcome

      hrp0086s6.2
    • Childhood Obesity Prevention: What Do We Need and How Are We Doing? A European Perspective

      hrp0086s6.3
  • Overgrowth disorders
  • • Abstract unavailable

      hrp0086s7.1
    • Abstract unavailable

      hrp0086s7.2
    • The Role of GPR101 in Human Growth

      hrp0086s7.3
  • Stem cells in endocrine organs
  • • Novel Function of Pituitary Stem Cells during Organ Homeostasis

      hrp0086s8.1
    • Pluripotent Stem Cells in Endocrinology

      hrp0086s8.2
    • Hubs in the Pancreas

      hrp0086s8.3
  • Recent advances in congenital adrenal hyperplasia
  • • Long-term Health in Congenital Adrenal Hyperplasia: Lessons from a National Study

      hrp0086s9.1
    • Recent Advances in CAH: New Approaches to Glucocorticoid Replacement

      hrp0086s9.2
    • Recent Advances in CAH: Treatments Saving GC Exposure

      hrp0086s9.3
  • Endocrine management of preterms
  • • Glucose Metabolism and Management in Premature Babies

      hrp0086s10.1
    • The gonadotropic axis in premature babies

      hrp0086s10.2
    • The Mineralcorticoid System and its Implications for Neonatal Adaptation in Premature Babies

      hrp0086s10.3
• Novel Advances & Controversies in Paediatric Endocrinology
• • Non-invasive prenatal diagnosis
  • • Abstract unavailable

      hrp0086na1.1
    • Intrauterine Imaging Strategies for Bone Disease

      hrp0086na1.2
  • Non-coding RNA in paediatric endocrinology
  • • De.Coding Obesity - Control of Metabolism by the Noncoding Transcriptome

      hrp0086na2.1
    • Abstract unavailable

      hrp0086na2.2
  • Challenges in the Management of DSD
  • • Abstract unavailable

      hrp0086con1.1
    • Surgical Management of DSD: New Insights

      hrp0086con1.2
    • Psychological Challenges

      hrp0086con1.3
    • An Ethicist's Viewpoint

      hrp0086con1.4
• Henning Anderson Award
• • KCNQ1 Mutations Cause Both Neonatal Diabetes and Hyperinsulinemic Hypoglycaemia of Infancy
  • • KCNQ1 Mutations Cause Both Neonatal Diabetes and Hyperinsulinemic Hypoglycaemia of Infancy

      hrp0086ha1
  • BOREALIN Mutations in Thyroid Dysgenesis Reveal a New Function of this Protein in Cell Adhesion and Migration
  • • BOREALIN Mutations in Thyroid Dysgenesis Reveal a New Function of this Protein in Cell Adhesion and Migration

      hrp0086ha2
• Working Groups
• • ESPE Disorders of Sex Development Working Group (DSD)
  • • Biological Determinants of Gender Identity

      hrp0086wg1.1
    • The Brain as a Target for Sex Steroids: Recent Trends in Endocrine Neuroimaging

      hrp0086wg1.2
    • Gender Dysphoria and DSD

      hrp0086wg1.3
    • Health Care Situation of Persons with dsd: Results From the dsd-LIFE Study

      hrp0086wg1.4
    • DSD Nomenclature, a Report of the Patients Views in the dsd-LIFE Study

      hrp0086wg1.5
    • Fertility in Persons with DSD, Results From the dsd-LIFE Study

      hrp0086wg1.6
  • ESPE Obesity Working Group (OWG)
  • • Abstract unavailable

      hrp0086wg2.1
    • Bariatric Surgery in Obese Adolescents

      hrp0086wg2.2
    • Clinical Approach To Severe Early Onset Childhood Obesity

      hrp0086wg2.3
    • Tanycyte Transport of Leptin into the Hypothalamus: Implications in Leptin Resistance

      hrp0086wg2.4
    • Palatability Can Drive Feeding Independent of AgRP Neurons

      hrp0086wg2.5
  • ESPE Turner Syndrome Working Group (TS)
  • • Spontaneous Fertility and Pregnancy Outcomes in Turner Syndrome

      hrp0086wg3.1
    • Skeletal Disproportion In Turner Syndrome

      hrp0086wg3.2
    • The Added Value of Experience Based Coaching and the Outcomes for Women with Turner Syndrome in the Netherlands

      hrp0086wg3.3
    • Face Perception in Turner Syndrome (TS)

      hrp0086wg3.4
    • Estradiol Supplementation in Turner Syndrome: An Update

      hrp0086wg3.5
  • ESPE Bone and Growth Plate Working Group (BGP)
  • • The Genetics of Overgrowth Syndromes

      hrp0086wg4.1
    • Hypercalcaemic Disorders in Children

      hrp0086wg4.2
    • Abstract unavailable

      hrp0086wg4.3
    • [ldquo]A Clinical and Genetic Approach to Diagnosis and Treatment of Fractures in Infancy[rdquo]

      hrp0086wg4.4
    • FGF23, Klotho and PTH in the Regulation of Mineral Homeostasis

      hrp0086wg4.5
  • ESPE Diabetes Technology and Therapeutics Working Group
  • • Abstract unavailable

      hrp0086wg5.1
    • SWEET: Developing Centers of Excellence (CoR)

      hrp0086wg5.2
    • Use and Discontinuation of Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring in Paediatric Patients with Type 1 Diabetes: Rates and Causes

      hrp0086wg5.3
    • Use of Dual Hormone (Glucagon) v. Single Hormone (Insulin) in the Treatment of Diabetes with Close-loop System

      hrp0086wg5.4
    • Use of Dual Hormone (Glucagone) vs Single Hormone (Insulin) in the Treatment of Diabetes with Closed-loop System

      hrp0086wg5.5
    • Prescribing Software for the Treatment of Diabetes

      hrp0086wg5.6
    • The Interaction Between Human and Technology in the Treatment of Diabetes

      hrp0086wg5.7
  • ESPE Paediatric and Adolescent Gynaecology Working Group (PAG)
  • • Abstract unavailable

      hrp0086wg6.1
    • Anorexia & Amenorrhea

      hrp0086wg6.2
    • Physical Exercise & Amenorrhea

      hrp0086wg6.3
    • Breast Cancer Risk in Adolescent Girls

      hrp0086wg6.4
    • Benign Breast Conditions in Adolescent Girls

      hrp0086wg6.5
  • ESPE Paediatric Endocrine Nurse Specialists and Allied Health Professionals Working Group (PENS)
  • • Abstract unavailable

      hrp0086wg7.1
    • The Activities of AdrenalNET and the Paedeatric Emergency Card for Europe

      hrp0086wg7.2
    • Empowering Nurses as Scholars

      hrp0086wg7.3
    • Poster Review

      hrp0086wg7.4
    • Abstract unavailable

      hrp0086wg7.5
• Free Communications
• • Adrenals
  • • DNA Methylation of HSD3B2, NUR77 and RAR[beta] Promoter Genes is Not Involved in functional Differentiation of Human Androgen-Producing Adrenocortical Cells

      hrp0086fc1.1
    • Transcriptomic Analysis in Healthy Subjects with Differences in Tissue Sensitivity to Glucocorticoids Identifies Novel Disease-associated Genes

      hrp0086fc1.2
    • Steroidogenesis in the Human Fetal Adrenals at the End of the First Trimester

      hrp0086fc1.3
    • Identification of Novel Central Nervous System Imaging Biomarkers Associated with Cognitive Abnormalities in Patients with Congenital Adrenal Hyperplasia

      hrp0086fc1.4
    • AAV Gene Therapy of 21-Hydroxylase Deficiency (21OHD) in Cyp21−/− mice

      hrp0086fc1.5
    • A Novel Syndrome of IUGR, Congenital Adrenal and Gonadal Insufficiency, Severe Infections, Thrombocytopenia and Monosomy 7 is Caused by SAMD9 Mutations

      hrp0086fc1.6
  • Bone & Mineral Metabolism
  • • Characterization of GNAS miRNAs Targets: Trying to Better Understand the Pathophysiology of Pseudohypoparathyroidism 1B (PHP1B)

      hrp0086fc2.1
    • From Pseudohypoparathyroidism to Inactivating PTH/PTHrP Signaling Disorder (iPPSD), a Novel Classification Proposed by the European EuroPHP-Network

      hrp0086fc2.2
    • The Impact of Intragastric Balloon Placement Suppported by a Lifestyle Intervention Programme on Cortical and Trabecular Microstructure and Strength in Severely Obese Adolescents

      hrp0086fc2.3
    • In vitro Evidence that Growth Plate Chondrocytes Differentiate into Perichondrial Cells

      hrp0086fc2.4
    • Determination of the Minimal Clinically Important Difference in the Six-Minute Walk Test for Patients with Hypophosphatasia

      hrp0086fc2.5
    • Effect of KRN23, a Fully Human Anti-FGF23 Monoclonal Antibody, on Rickets in Children with X-linked Hypophosphatemia (XLH): 40-week Interim Results from a Randomized, Open-label Phase 2 Study

      hrp0086fc2.6
  • Pituitary
  • • The MAPK Effector BRAF is Essential for the Integrity of Hypothalamic-Pituitary Development and Deregulation of this Pathway Causes Congenital Hypopituitarism

      hrp0086fc3.1
    • Spectrum of LHX4 Mutations in a Cohort of 510 Patients with Hypopituitarism

      hrp0086fc3.2
    • Contribution of GLI2 Mutations to Pituitary Deficits and Delineation of the Associated Phenotypic Spectrum

      hrp0086fc3.3
    • A Novel Mutation in Eukaryotic Translation Initiation Factor 2 Subunit 3 (EIF2S3) is Associated with X-Linked Hypopituitarism and Glucose Dysregulation

      hrp0086fc3.4
    • Septo-optic Dysplasia Spectrum: Pubertal Features of a Large Cohort of Children and Adolescents with Septo-optic Dysplasia, Congenital Hypopituitarism and Optic Nerve Hypoplasia from a Single Centre

      hrp0086fc3.5
    • Pegvisomant is More Effective in Stunting Growth than Somatostatin Analogs in Childhood Acromegaly/Gigantism

      hrp0086fc3.6
  • Pathophysiology of Obesity
  • • Contribution of Rare CNVs and Point Mutations to the Etiology of Severe Early-onset Obesity

      hrp0086fc4.1
    • Immune-Fat-Bone Axis in Obese Children: The Role of LIGHT

      hrp0086fc4.2
    • Expression of Type 1 Insulin-like Growth Factor Receptor (IGF-1R) in Liver of Obese Children with Non-alcoholic Fatty Liver Disease (NAFLD)

      hrp0086fc4.3
    • The Role of Apoptotic Marker Apo-1/Fas in the Metabolism and Endothelial Function of Healthy Children

      hrp0086fc4.4
    • Novel Association between the Non-synonymous A803G Polymorphism of the N-acetyltransferase 2 Gene and Impaired Glucose Homeostasis in Obese Children and Adolescents

      hrp0086fc4.5
    • The Rise and Fall of the Swedish Childhood Obesity Epidemic - The BEST Cohort

      hrp0086fc4.6
  • Management of Disorders of Insulin Secretion
  • • The Anti-diabetic Drug, Metformin, Suppresses Adipogenesis through both AMP-activated Protein Kinase (AMPK)-dependent and AMPK-independent Mechanisms

      hrp0086fc5.1
    • Diabetes and Insulin Injection Modalities: Effects on Hepatic Expression and Activity of 11[beta]-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Rats

      hrp0086fc5.2
    • Glibentek, a New Suspension of Glibenclamide for Patients with Neonatal Diabetes, is as Effective and more Convenient than Crushed Tablets

      hrp0086fc5.3
    • Persistent Beneficial Metabolic Effect after Five Years in a Cohort of 28 Subjects with Neonatal Diabetes owing to Potassium Channel Mutation and Transferred from Insulin to Sulfonylureas

      hrp0086fc5.4
    • DPP-4 Inhibitor is an Alternative Effective Treatment in a Common Cause of Anti-GAD Negative [ldquo]Type 1 Diabetes[rdquo] - A Founder CISD2 Mutation

      hrp0086fc5.5
    • Impact of Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections on Bone Health in Children and Adolescents with Type 1 Diabetes

      hrp0086fc5.6
  • Syndromes: Mechanisms and Management
  • • Ghrelin-Reactive Autoantibodies are Elevated in Children with Prader-Willi Syndrome Compared to Unaffected Sibling Controls

      hrp0086fc6.1
    • Whole Exome Sequencing Identifies EPHB4 and PIk3R6 as Causes of Generalized Lymphatic Anomaly

      hrp0086fc6.2
    • Oxytocin Improves Social and Food-Related Behavior in Young Children with Prader-Willi Syndrome: A Randomized, Double-Blind, Controlled Crossover Trial

      hrp0086fc6.3
    • Chromosome 14 Imprinted Region DLK1/GTL2 Disruption: An Alternative Molecular Etiology for Silver-Russell Syndrome

      hrp0086fc6.4
    • Pathogenic Copy Number Variants are Frequently Identified in Children with Short Stature of Unknown Etiology

      hrp0086fc6.5
    • Social Cognition Skills and Face Perception in Turner Syndrome (TS)

      hrp0086fc6.6
  • Gonads & DSD
  • • Early Loss of Germ Cells in Testis of Androgen Insensitivity Syndrome Patients

      hrp0086fc7.1
    • Serum Irisin Concentrations in Lean Adolescents with Polycystic Ovary Syndrome

      hrp0086fc7.2
    • Estrogen Insensitivity due to a Novel ESR1 Mutation in a Consanguineous Family from Algeria

      hrp0086fc7.3
    • Disruption of Long-Range Transcriptional Regulation of Genes Known to be Associated with DSD

      hrp0086fc7.4
    • Targeted Exome Sequencing for Genetic Diagnosis of Patients with Disorders of Sex Development

      hrp0086fc7.5
    • Whole-Exome Sequencing Reveals RAD51B Variant in Two Sisters with Primary Ovarian Failure

      hrp0086fc7.6
  • Growth: Clinical
  • • Transcriptomics and Machine Learning Methods Accurately Predict Diagnosis and Severity of Childhood Growth Hormone Deficiency

      hrp0086fc8.1
    • Whole Exome Sequencing can Identify Defects not Detected by Candidate Gene Sequencing in Patients with Short Stature and Features of Growth Hormone Insensitivity (GHI)

      hrp0086fc8.2
    • PAPP-A2 Gene Mutation Effects on Glucose Metabolism and Bone Mineral Density and Response to Therapy with Recombinant Human IGF-I

      hrp0086fc8.3
    • Genetic Insights from Children with Idiopathic Short Stature in the EPIGROW Study

      hrp0086fc8.4
    • Longitudinal Study on Body Composition, Insulin Sensitivity and [beta]-cell Function in SGA Adults from Stop of Long-term GH Treatment until 5 Years after Stop

      hrp0086fc8.5
    • Birth Characteristics Explain One Third of Expected Deaths in rhGH-treated Patients Diagnosed with IGHD, ISS & SGA

      hrp0086fc8.6
  • Pathophysiology of Disorders of Insulin Secretion
  • • Next Generation Sequencing for the Diagnosis of Monogenic Diabetes in Switzerland

      hrp0086fc9.1
    • NBAS Mutations, a New Monogenic Cause of DISOPHAL, a New Syndrome with Type 1 Diabetes (T1D)

      hrp0086fc9.2
    • Gastrointestinal Dysmotility and Pancreatic Exocrine Insufficiency as Newly Recognised Possible Features in Two Siblings with Donohue Syndrome

      hrp0086fc9.3
    • The Protective Effects of Adenovirus-mediated IL-10 Gene and Anti-CD20 Monoclonal Antibody on the Pancreatic [beta] Cells of NOD Mice in the Early Stage of Natural T1D Onset

      hrp0086fc9.4
    • Evaluation of a Novel Method to Detect Residual sz-Cell Function by Dried Blood Spots in Children and Adolescents with a Recent Diagnosis of Type 1 Diabetes

      hrp0086fc9.5
    • Circulating Angiopoietin-2 Levels in Young Patients with Type 1 Diabetes Mellitus: A Link between Inflammation, Micro-Vascular Complications and Subclinical Atherosclerosis

      hrp0086fc9.6
  • Perinatal Endocrinology
  • • CYP11B1 Deficiency in Very Preterms: Evidence for an Adrenal Cortex Zone-Specific and Developmental-Dependent Maturation

      hrp0086fc10.1
    • Liver UPR and Metabolic Consequences in an Animal Model of Intrauterine Growth Retardation (IUGR)

      hrp0086fc10.2
    • Pharmacokinetics of Long Acting Somatostatin Analogue (Lanreotide) Therapy in Hyperinsulinaemic Hypoglycaemia (HH) and Understanding its Molecular Action via Somatostatin Receptors by Immunohistochemistry

      hrp0086fc10.3
    • In Utero and Postnatal Consequences of Psychological Maternal Stress have Different Effects On Longevity: Studies in World War 1 Orphans

      hrp0086fc10.4
    • Effects of Developmental Bisphenol A Exposure on Spermatozoal microRNA Expression

      hrp0086fc10.5
    • Developmental Programming of Somatic Growth, Behavior and the Endocannabinoid System (ECS) by Variation of Early Postnatal Nutrition in a Cross-Fostering Mouse Model

      hrp0086fc10.6
  • Thyroid
  • • Mutations in TBL1X as a Novel Cause of Familial Central Hypothyroidism

      hrp0086fc11.1
    • Overexpression of DYRK1A Located in the Down Syndrome Critical Region, Leads to Primary Hypothyroidism in Down Syndrome through Interaction with FOXE1

      hrp0086fc11.2
    • Genetic Heterogeneity Revealed by WES in a Cohort of Patients with Brain-Lung-Thyroid Syndrome

      hrp0086fc11.3
    • Decreased Proportions of CD4+IL17+/CD4+CD25+CD127− and CD4+IL17+/CD4+CD25+CD127-FoxP3+T Cells in Children with Autoimmune Thyroid Diseases

      hrp0086fc11.4
    • Pediatric Reference Values of Thyrotropin (TSH) should be Personalized According to Child Characteristics

      hrp0086fc11.5
    • Too many TFTs? A Change in Neonatal Thyroid Function Testing in a Peripheral Hospital in Ireland

      hrp0086fc11.6
  • Neuroendocrinology
  • • Rabconnectin3-[alpha] is Indispensable for the Activation and Maturation of the GnRH Neuronal Network

      hrp0086fc12.1
    • LGR4 and EAP1 Mutations are Implicated in the Phenotype of Self-limited Delayed Puberty

      hrp0086fc12.2
    • Inactivating Mutations in CCDC141 Causing Idiopathic Hypogonadotrophic Hypogonadism/Kallmann Syndrome

      hrp0086fc12.3
    • Idiopathic Hypogonadotrophic Hypogonadism Caused by Inactivating Mutations in SRA1

      hrp0086fc12.4
    • Abnormal Corticospinal Tract Decussation in Kallmann Syndrome due to ANOS1 (KAL1) Mutations: An Explanation of the Mirror Movements Frequently Observed in These Patients

      hrp0086fc12.5
    • Pubertal Onset in Boys is Influenced by BMI and Genetic Variation of Fshb and Fshr: A Study in Two Population-Based Cohorts of Different Genetic Ancestry

      hrp0086fc12.6
  • Management of Obesity
  • • Quantitative Proteomic of Rat Livers Shows a Major Reprogramming of Mitochondrial Enzymes in Food-Restriction and Increased Stress Hallmarks in Ad Libitum Feeding

      hrp0086fc13.1
    • Measurement of Immunofunctional Leptin to Detect Patients with Functional Leptin Deficiency

      hrp0086fc13.2
    • Hypothalamic Gliosis in Obese Children and Adolescents

      hrp0086fc13.3
    • Efficacy and Safety of Duodenal-Jejunal Bypass Liner in Morbidly Obese Adolescents-1 Year Experience

      hrp0086fc13.4
    • Effects of AZP-531, a First-in-Class Unacylated Ghrelin Analog, on Food-Related Behaviour in Prader-Willi Patients: A Multi-Center, Randomized, Placebo-Controlled Study

      hrp0086fc13.5
    • Treatment for Early Onset and Extreme Obesity in Two POMC Deficient Patients: Successful Weight Loss with the Melanocortin-4 Receptor Agonist Setmelanotide

      hrp0086fc13.6
  • Growth : Mechanisms
  • • Clinical Characterization of Children with Autosomal Dominant Short Stature due to Aggrecan Mutations Broadens the Phenotypic Spectrum

      hrp0086fc14.1
    • CG Methylation at the IGF1 P2 Promoter is a Major Epigenetic Determinant of Postnatal, Not Foetal Growth

      hrp0086fc14.2
    • CG at the Methylation IGF1 Locus is an Epigenetic Predictor of GH Sensitivity

      hrp0086fc14.3
    • Preferential Paternal Transmission of the T Allele for the rs1802710 Polymorphism In Dlk1 Gene as a Pre- and Postnatal Growth Regulator

      hrp0086fc14.4
    • Preferential Transmission of the Paternal C Allele of the rs9373409 Polymorphism in plagl1 Gene as a Regulator of Fetal Growth and Maternal Metabolism

      hrp0086fc14.5
    • In vitro and in vivo Evidence for a Growth Inhibitory Role of the Transcription Factor ZBTB38 Throughout Pre- and Post-Natal Life

      hrp0086fc14.6
  • Late Breaking
  • • NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of development

      hrp0086fc15.1
    • Mutations in SGPL1, the Gene Encoding Sphingosine-1-Phosphate Lyase, Cause a Novel Form of Primary Adrenal Insufficiency with Steroid Resistant Nephrotic Syndrome

      hrp0086fc15.2
    • Contribution of Next Generation Sequencing Approach for Management of Congenital Hypothyroidism with Eutopic Thyroid Gland

      hrp0086fc15.3
    • Vitamin D-Dependent Rickets Type 1 Caused by Mutations in CYP27B1 Affecting Protein Interactions with Adrenodoxin

      hrp0086fc15.4
    • Effect of Conjugated Linoleic Acid and Metformin on Insulin Sensitivity, Measured by Euglycemic-Hyperinsulinemic Clamp Technique, in Children with obesity: A Randomized, Double-Blinded, Placebo-Controlled Trial

      hrp0086fc15.5
    • Type 1 Diabetes Associated Serum Insulin-Like Growth Factor I (IGF-I) Reference Values in Children and Adolescents

      hrp0086fc15.6
• Rapid Free Communications
• • Adrenals
  • • Tracing the Glucocorticoid Receptor Evolutionary Pedigree: Insights from a Comprehensive Phylogenetic Analysis of the Full NR Super-Family

      hrp0086rfc1.1
    • Glucocorticoid Deficiency Due to Disruption of Mitochondrial Steroidogenesis Leads to Dysregulation of Antioxidant Pathways and Nucleotide Biosynthesis

      hrp0086rfc1.2
    • Impaired Cardiac Function in a Mouse Model of Generalized Glucocorticoid Resistance

      hrp0086rfc1.3
    • Mutations of ABCD1 in 16 Vietnamese Patients with X-linked Adrenoleukodystrophy

      hrp0086rfc1.4
    • A Novel Animal Model to Study 21-Hydroxylase Deficiency in vivo

      hrp0086rfc1.5
    • Pediatric Patients with Congenital Adrenal Hyperplasia have Unfavorable Changes in their Cardiovascular Risk Profile

      hrp0086rfc1.6
    • The Recovery of Adrenal Function in Children with Chronic Asthma Assessed by Low Dose Short Synacthen Test (LDSST)

      hrp0086rfc1.7
    • Adrenal Dysfunction in HIV-Exposed Uninfected Infants Receiving Ritonavir-Boosted Lopinavir, an HIV Protease Inhibitor, for the Prevention of Breastfeeding HIV Transmission. An ANRS 12174 Substudy

      hrp0086rfc1.8
  • Bone & Mineral Metabolism
  • • 25-OH-Vitamin D Status in a Pediatric Population of Subjects Affected By Prader-Willi Syndrome Compared to Matched Obese Controls

      hrp0086rfc2.1
    • Duration of Exclusive Breastfeeding: 'Game Changer' in a Sex-Specific Association Between Cord Vitamin D Status and Infant Linear Growth

      hrp0086rfc2.2
    • Cord Vitamin D is Inversely Associated with Systolic and Diastolic Blood Pressure in 3-Year-Old Girls, but not in Boys

      hrp0086rfc2.3
    • Results of Orthopaedic Surgery in Children with X-Linked Hypophosphatemic Rickets (XLHR)

      hrp0086rfc2.4
    • Growth Patterns and Fractures in Boys with Duchenne Muscular Dystrophy: Insights from Over 800 Boys in the UK North Star Cohort

      hrp0086rfc2.5
    • Combining COLD and MAMA-PCR Real Time Taqman Tecniques to Detect and Quantify the R201 GNAS Mutation Causing McCune-Albright Syndrome

      hrp0086rfc2.6
    • Effect of Paternal Loss-of-Function Mutations of GNAS on Growth During the Childhood: A Role for XL

      hrp0086rfc2.7
    • Final Heights and BMI in Patients Affected with Different Types of Pseudohypoparathyroidism

      hrp0086rfc2.8
  • Pituitary
  • • Endocrinopathy in Childhood Intracranial Germ Cell Tumours is Predicted by Disease Location not Treatment: 30 year Experience from a Single Tertiary Centre

      hrp0086rfc3.1
    • Subfertility After Chemotherapy in PNET Tumours: 34 year Experience from a Single Centre (1980-2013)

      hrp0086rfc3.2
    • Unraveling the Link between Optic Nerve Hypoplasia and Pituitary Hormone Dysfunction

      hrp0086rfc3.3
    • Children and Adolescents with Severe TBI can Develop Late Pituitary Dysfunction Independently of the Results of the First Pituitary Evaluation

      hrp0086rfc3.4
    • Prospective Dynamic Evaluation of Hypothalamo-Pituitary Function in 30 Cases of Paediatric Craniopharyngioma, by Hypothalamic Injury and Treatment; A Single Centre Series

      hrp0086rfc3.5
    • Priority Target Conditions of Growth-Monitoring in Children: Toward Consensus

      hrp0086rfc3.6
    • Pituitary Structural Abnormalities in Idiopathic Isolated Growth Hormone Deficiency

      hrp0086rfc3.7
    • Anthropometric and Endocrine Features in Children and Adolescents with Type 1 Narcolepsy

      hrp0086rfc3.8
  • Pathophysiology of Obesity
  • • Adipocytokines Delay Pubertal Maturation of Human Sertoli Cells

      hrp0086rfc4.2
    • Early Growth Patterns are Associated with Alterations in Adipocytokine Levels and Fat Distribution Measured by DXA in 982 Children/Adolescents

      hrp0086rfc4.3
    • Metabolic Syndrome Markers Correlate with Gut Microbiome Activity in Children Born Very Preterm

      hrp0086rfc4.4
    • Steroid Metabolomic Signature of Liver Disease in Childhood Obesity

      hrp0086rfc4.5
    • Adipose Tissue - A Source of Hyperandrogenism in Obese Females?

      hrp0086rfc4.6
    • Prevalence and Characterization of Retinal Alterations in a Cohort of Overweight and Obese Children

      hrp0086rfc4.7
  • Management of Disorders of Insulin Secretion
  • • Adiponectin and Leptin in Children with Type 1 Diabetes for 3-5 years with or without Residual [beta] cell Function

      hrp0086rfc5.1
    • Limits of Agreement between HbA1c Levels Measured in Different Laboratories Following the Introduction of the International Federation of Clinical Chemistry and Laboratory Medicine Standardised Values

      hrp0086rfc5.2
    • Sexual Lifestyle among Young Adults with Type 1 Diabetes

      hrp0086rfc5.3
    • [ldquo]Transient[rdquo] Neonatal Diabetes In Adulthood: Metabolic Outcomes

      hrp0086rfc5.4
    • The Efficacy of Insulin Degludec in Children and Adolescents with Type 1 Diabetes

      hrp0086rfc5.5
    • Clinical Management of the Mitchell-Riley Syndrome Due to RFX6 Gene Mutations: Aggressive Support Results in Improved Outcome

      hrp0086rfc5.6
    • Early Successful Hematopoietic Cell Transplantation (HSCT) in a Boy with IPEX Syndrome Caused by Novel C.721T>C FOXP3 Mutation

      hrp0086rfc5.7
    • Stress Management and Health Promotion through Family Intervention Improves Metabolic Control in Children and Adolescents with Type 1 Diabetes

      hrp0086rfc5.8
  • Syndromes: Mechanisms and Management
  • • RAB3IP and DGCR8 as a Potentially Pathogenic Novel Candidate Gene Involving in Growth Disorders

      hrp0086rfc6.2
    • Effect of Very Early Growth Hormone (GH) Treatment on Long-term Growth in Girls with Turner Syndrome (TS): A Multicenter, Open-Label, Extension Study

      hrp0086rfc6.3
    • Growth Hormone (GH) Treatment in Skeletal Dysplasias - Short-term Results in Prepubertal Children Reported in KIGS

      hrp0086rfc6.4
    • Abnormal Videofluoroscopic Swallow Studies (VFSS) in Infants with Prader-Willi Syndrome Indicate a High Rate of Silent Aspiration

      hrp0086rfc6.5
    • Growth Hormone (GH) Deficiency Type II: Clinical and Molecular Evidence of Impaired Regulated GH Secretion Due to an Gln181Arg GH-1 Gene Mutation

      hrp0086rfc6.6
    • Characteristics of Responders and Poor-responders to Increlex® Therapy - Data from Children Enrolled in the European Increlex® Growth Forum Database (EU-IGFD)

      hrp0086rfc6.7
    • The Actual Incidence of Small for Gestational Age (SGA) Newborns and their Catch-up Growth is Dramatically Lower than Previously Considered

      hrp0086rfc6.8
  • Gonads & DSD
  • • Tissue Engineered Collagen Based Tubular Scaffolds for Urethral Regeneration. A Novel Technology for the Surgical Treatment of VSD (Variation of Sex Development) Patients with Severe Hypospadias

      hrp0086rfc7.1
    • Reference Values for External Genitalia Size and Steroid Hormone Levels in Female Neonates

      hrp0086rfc7.2
    • Harmonisation of Serum Dihydrotestosterone Analysis: Establishment of an External Quality Assurance Program

      hrp0086rfc7.3
    • A Mutation in WT1 (Wilms' Tumor Suppressor 1) Associated with 46,XX TDSD

      hrp0086rfc7.4
    • Fertility Preservation in an Adolescent Boy: Inducing Puberty and Spermatogenesis Prior to Bone Marrow Transplantation

      hrp0086rfc7.5
    • The Hopeful Beginnings of Fertility Preservation in Children

      hrp0086rfc7.6
    • Clinical Decision-Making in Disorders of Sex Development (DSD): Physician Recommendations Pre- and Post-Consensus Statement

      hrp0086rfc7.7
    • Premature Adrenarche in Girls at Pubertal Onset is Associated with High Androgens, but Lower AMH Concentrations

      hrp0086rfc7.8
  • Growth: Clinical
  • • Somavaratan (VRS-317) Treatment of Children with Growth Hormone Deficiency (GHD): Results at 2 Years (NCT02068521)

      hrp0086rfc8.1
    • Pharmacokinetic Modelling Predicts Native hGH Levels Following Administration of a Sustained-Release Prodrug, TransCon hGH, to Children with GHD

      hrp0086rfc8.2
    • Batch-to-Batch Consistency of a Highly O-Glycosylated Long-Acting Human Growth Hormone (MOD-4023)

      hrp0086rfc8.3
    • A Hybrid Fc-fused Human Growth Hormone, GX-H9, Shows a Potential for Weekly and Semi-monthly Administration in Clinical Studies

      hrp0086rfc8.4
    • Optimal Sampling of IGF-1 During Weekly Administration of a Long Acting Human Growth Hormone (MOD 4023)

      hrp0086rfc8.5
    • A Six-Month Safety and Efficacy Study of TransCon hGH Compared to Daily hGH in Pre-Pubertal Children with Growth Hormone Deficiency (GHD)

      hrp0086rfc8.6
    • Safety and Tolerability of Once-Weekly Administration of CTP-Modified Human Growth Hormone (MOD-4023): 24-month Complete Dataset Results of a Phase 2 Study in Children with Growth Hormone Deficiency

      hrp0086rfc8.7
    • Efficacy of Once-Weekly Administration of CTP-Modified Human Growth Hormone (MOD-4023): 24-month Complete Database Results of a Phase 2 Study in Children with Growth Hormone Deficiency

      hrp0086rfc8.8
  • Pathophysiology of Disorders of Insulin Secretion
  • • Neonatal Diabetes due to NKX2.2 Mutation - Genotype, Clinical Phenotype and Therapeutic Challenges in a Very Low Birth Weight Diabetic Neonate

      hrp0086rfc9.1
    • Missense Mutation of GLIS3 Gene Resulting in Neonatal Diabetes and Congenital Hypothyroidism

      hrp0086rfc9.2
    • Molecular Analysis of a Large Cohort of MODY Patients by Next Generation Sequencing

      hrp0086rfc9.3
    • Prevalence of Monogenic Diabetes in the Lithuanian Pediatric and Young Adult Population

      hrp0086rfc9.4
    • Non-Mody Monogenic Diabetes: A Very Heterogenous and Problematic Group of Diabetes

      hrp0086rfc9.5
    • Emerging Pitfalls of Etiological Diagnosis of Diabetes in Children and Adolescents? Analysis of a French Cohort of 310 Recent-Onset Cases

      hrp0086rfc9.6
    • Chronotype and Type 2 Diabetes Risk in Preadolescents

      hrp0086rfc9.7
    • Micro RNA and Diabetic Nephropathy

      hrp0086rfc9.8
  • Perinatal Endocrinology
  • • Paternal Loss-of-Function Mutations of GNAS and Growth Retardation in a Mice Model: A Specific Placental Transcriptomic Signature?

      hrp0086rfc10.1
    • Dysregulation of Placental Mirna in Maternal Obesity is Associated with Pre-and Post-Natal Growth

      hrp0086rfc10.2
    • Vitamin D Depletion in Pregnancy Decreases Survival Time, Oxygen Saturation, Lung Weight and Body Weight in Preterm Rat Offspring

      hrp0086rfc10.3
    • Pharmacokinetics of Intravenous Glucagon in Children with Hyperinsulinaemic Hypoglycaemia

      hrp0086rfc10.4
    • Phenotype, Genotype and Short term Outcome in Congenital Hyperinsulinism (CHI)

      hrp0086rfc10.5
    • Increased Islet Cell Neogenesis and Endocrine Cell Differentiation in Congenital Hyperinsulinism in Infancy

      hrp0086rfc10.6
    • Expression of Insulin Receptor Isoforms and Type 1 Insulin-Like Growth Factor Receptor in the Placenta as a Function of Fetal Weight

      hrp0086rfc10.7
    • Gestational Diabetes is Associated with Changes in Placental Microbiota and Microbiome

      hrp0086rfc10.8
  • Thyroid
  • • Central Hypothyroidism and Biallelic Defect Near the D/ERY Motif of the TRHR Gene

      hrp0086rfc11.1
    • The Incidence and Genetic Analysis of Congenital Hypothyroidism in Guangxi, China and the Predictors for Differentiating Permanent and Transient Congenital Hypothyroidism

      hrp0086rfc11.2
    • Germline and Somatic DICER1 Mutations in Familial Papillary Thyroid Carcinoma and Multinodular Goiter

      hrp0086rfc11.3
    • Thyroid Function in Monozygotic Twins with Intra-Twin Birth-Weight-Differences

      hrp0086rfc11.4
    • Novel Homozygous Mutation in the Sodium/Iodide Symporter (NIS) Gene Highlight by Next Generation Sequencing (NGS) in a Patient with Congenital Hypothyroidism

      hrp0086rfc11.5
    • Falsely TSH and Free Thyroid Hormone Measurements in Pediatric Patients Treated with High Dose of Biotin

      hrp0086rfc11.6
    • Secondary Thyroid Cancer among Childhood Cancer Survivors: A Single Institution Experience

      hrp0086rfc11.7
  • Neuroendocrinology
  • • Molecular Genetic Diagnosis of Idiopathic Hypogonadotropic Hypogonadism by Using Targeted Next-Generation Sequencing

      hrp0086rfc12.1
    • A Novel Mutation of KISS1R Causing a Normosmic Isolated Hypogonadotropic Hypogonadism

      hrp0086rfc12.2
    • Next Generation Sequencing and Precocious Puberty: A New Diagnostic Challenge to Identify the Molecular Basis of Complex Diseases

      hrp0086rfc12.3
    • Molecular Screening of MKRN3, DLK1 and KCNK9 Genes in Central Precocious Puberty

      hrp0086rfc12.4
    • A Novel MKRN3 Nonsense Mutation Causing Familial Central Precocious Puberty

      hrp0086rfc12.5
    • Serum Antimullerian Hormone and Inhibin B as Potential Markers for Progressive Central Precocious Puberty in Girls

      hrp0086rfc12.6
    • Prevalence of Organic Lesions in Males with Central Precocious Puberty

      hrp0086rfc12.7
    • Circulating MKRN3 Levels Decline During Puberty in Healthy Boys

      hrp0086rfc12.8
  • Management of Obesity
  • • Inhibition of Teneurin-2 (TENM2) Leads to Upregulation of UCP1 in Human White Adipocytes

      hrp0086rfc13.1
    • The Use of Proteomics in the Assessment of Health Status of Offspring Born after Intracytoplasmic Sperm Injection (ICSI)

      hrp0086rfc13.2
    • Effects of Eating Rate on Satiety Hormones, Meal Enjoyment and Memory for Recent Eating: An fMRI Study

      hrp0086rfc13.3
    • Which Amount of BMI-SDS Reduction is Necessary to Improve Cardiovascular Risk Factors in Overweight and Obese Children?

      hrp0086rfc13.4
    • Protective Potential of Metformin on Membrane Linked Functions in Diabetic Aging Female Rats

      hrp0086rfc13.5
    • Laparoscopic Sleeve Gastrectomy in Obese Adolescent Population

      hrp0086rfc13.6
    • Early Onset Obesity and Hyperphagia Associated with Defects in the GNAS Gene

      hrp0086rfc13.7
    • Measuring Subcutaneous Adipose Tissue Using Ultrasound in Children

      hrp0086rfc13.8
  • Growth : Mechanisms
  • • Important Contribution of GH, GHRHR and GHSR Mutations in Isolated Growth Hormone Deficiency with a Normal Location of the Posterior Pituitary -Functional Characterization of New Variants

      hrp0086rfc14.1
    • Contribution of GHR and IGFALS Mutations to Growth Hormone Resistance - Identification of New Variants and Impact on the Inheritance Pattern

      hrp0086rfc14.2
    • Whole Exome Sequencing Identifies a GH1 Gene Mutation Causing Familial Isolated Growth Hormone Deficiency with Normal Peak Growth Hormone Concentrations

      hrp0086rfc14.3
    • Genetic Diagnosis of Congenital Growth Hormone Deficiency by Massive Parallel Sequencing Using a Target Gene Panel

      hrp0086rfc14.4
    • Gene Expression Profiling of Children with GH Deficiency (GHD) Prior to Treatment with Recombinant Human Growth Hormone (r-hGH) is Associated with Growth Response Over Five Years of Therapy

      hrp0086rfc14.5
    • Effect of Small Size at Birth, Adult Body Size and Growth Hormone Treatment on Telomere Length

      hrp0086rfc14.6
    • GH Influences Plasma Fasting Adropin Concentration in Patients with Turner Syndrome

      hrp0086rfc14.7
    • ACAN Mutations in Short Children Born SGA; Growth Response During GH Treatment with Additional GnRHa, and a Proposed Clinical Scoring System

      hrp0086rfc14.8
  • Late Breaking
  • • A Novel Homozygous Mutation in the Domain AF-2 of Alpha Estrogen Receptor Gene (ESR1), Generating a Bio-Inactive ER[alpha] Mutant, Resulting in Estrogen Resistance with Complex Metabolic Phenotype

      hrp0086rfc15.1
    • NR0B1 Frameshift Mutation in a Boy with Precocious Puberty and Normal Adrenal Function

      hrp0086rfc15.2
    • Abstract unavailable

      hrp0086rfc15.3
    • The Effect of Sfrp5, Wnt5a, Adiponectin, and Chemerin on Blood Pressure Regulation in Obese Children

      hrp0086rfc15.4
    • Effect of Melatonin on Proliferation and Differentiation of Human Dental Pulp Cells

      hrp0086rfc15.5
    • Safety of GH in Paediatrics: The GeNeSIS Prospective Observational Study Experience between 1999 and 2015 (NCT01088412)

      hrp0086rfc15.6
    • Long-Term Safety and Effectiveness of Daily and Weekly Growth Hormone Treatment in Pediatric GHD Patients (4-Years' Results)

      hrp0086rfc15.7
    • Replacement of Male Mini-Puberty

      hrp0086rfc15.8
• Poster Presentations
• • Adrenal P1
  • • Leptin is Associated with Serum Aldosterone in Paediatric Subjects, Independently of Body Mass Index, Blood Pressure and Plasma Renin Activity

      hrp0086p1-p1
    • Mast Cells and Steroidogenesis in the Human Fetal Adrenal

      hrp0086p1-p2
    • Gender-Specific Differences in Hypothalamus-Pituitary-Adrenal Axis Activity in Children: A Meta-Analysis

      hrp0086p1-p3
    • Prepubertal Children Born Large for Gestational Age have Lower Serum DHEAS Concentrations than those with Lower Birth Weight

      hrp0086p1-p4
    • Whole Exome Sequencing in Patients with Primary Generalized Glucocorticoid Resistance, who did not have Mutations in the NR3C1 Gene

      hrp0086p1-p5
    • Novel CYP11A1 Mutations in 15 Patients (13 Families) with Variable Clinical Presentations

      hrp0086p1-p6
    • Transient Generalized Glucocorticoid Hypersensitivity Syndrome

      hrp0086p1-p7
    • The Effect of Obesity on the Stress Response: The Paradigm of Surgical Stress

      hrp0086p1-p8
    • Long-term Anthropometric Outcome of Girls with Non-classical Congenital Adrenal Hyperplasia Diagnosed in Childhood

      hrp0086p1-p9
    • Current Dilution Methods Cause Large Variations and Inaccuracies when Making up 1 μg Synacthen Dose

      hrp0086p1-p10
    • Evaluation of the Glucocorticoid, Mineralocorticoid, and Adrenal Androgen Secretion Dynamics in A Large Cohort of Patients Aged 6-18 Years with Transfusion-dependent [beta]-Thalassemia Major, with an Emphasis on the Impact of Cardiac Iron Load

      hrp0086p1-p11
    • Testicular Adrenal Rest Tumours in 50 Boys, Adolescents and Adult Male with Congenital Adrenal Hyperplasia

      hrp0086p1-p12
    • Establishment of Clinical and Lab Algorithms for the Identification Carriers of Mutations in CYP21A2 - A Study of 768 Children and Adolescents

      hrp0086p1-p13
    • A Unique Case of Dual Opposing Pathologies

      hrp0086p1-p14
    • Individualized Optimization with 17OHP-Saliva Profiles Leads to Changes in Hydrocortisone Dosing Pattern in Children with Congenital Adrenal Hyperplasia

      hrp0086p1-p15
    • Cortisol Response to ACTH Stimulation Test in Non-Classical Congenital Adrenal Hyperplasia

      hrp0086p1-p16
    • Altered Stress System Activity in Children with ADHD

      hrp0086p1-p17
    • Adult Individuals with Classic Congenital Adrenal Hyperplasia Exhibit Deficits in Executive Functions

      hrp0086p1-p18
    • Heterozygous Mutations in CYP11A1 Gene can Cause Life-Threatening Salt Wasting and Failure to Thrive

      hrp0086p1-p19
    • HIV Drugs as a Possible Cause for Transient 21-Hydroxylase Deficiency in a Preterm Infant

      hrp0086p1-p20
    • Increased Salivary and Hair Cortisol and Decreased Salivary Alpha-Amylase Concentrations in Obese Prepubertal Girls

      hrp0086p1-p21
    • An Assessment of the Hypothalamic-Pituitary-Adrenal Axis in Children with Prader-Willi Syndrome

      hrp0086p1-p22
    • The Urinary Steroidome of Children with Classic 21-Hydroxylase Deficiency Treated with Hydrocortisone

      hrp0086p1-p23
    • Adrenal Insufficiency in ROHHADNET Syndrome (Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, Autonomic Dysregulation and Neural Tumor)

      hrp0086p1-p24
    • The Psychosocial Impact of Adrenal Insufficiency and Congenital Adrenal Hyperplasia on Children and their Parents

      hrp0086p1-p25
    • Sex-Specific Differences in Hypothalamus-Pituitary-Adrenal Axis Activity in Newborns with Very Low Birth Weight

      hrp0086p1-p26
    • Beckwith-Wiedemann Syndrome and Bilateral Phaeochromocytoma: A Diagnostic Challenge

      hrp0086p1-p27
    • Combined Glucocorticoid and Mineralocorticoid Deficiency Related to a New NNT Mutation: A Case Report

      hrp0086p1-p28
    • Testicular Adrenal Rest Tumours in Patient with X-Linked Adrenoleukodystrophy

      hrp0086p1-p29
    • Reference Intervals for the Steroid Hormones of 6 to 14 year Old Normal Male Children with LC-MS Method

      hrp0086p1-p30
    • Growth of Children with Congenital Adrenal Hyperplasia (CAH) During the First 2 years of Life - Data from the Duth Longitudinal Registry

      hrp0086p1-p31
    • Molecular Confirmatory Test Improves the Accuracy of Congenital Adrenal Hyperplasia Diagnosis in Newborn Screening Program

      hrp0086p1-p32
    • Usefulness of Corticotropin Test in Children and Adolescents with Clinical Hyperandrogenism

      hrp0086p1-p33
    • Primary Adrenal Insufficiency in Children: Results from a Large Nationwide Cohort

      hrp0086p1-p34
    • Follow-up of Growth and Puberty in Girls and Boys with Premature Adrenarche

      hrp0086p1-p35
    • Early Onset Hypertension with Primary Hyperaldosteronism through Mutation in the Calcium Channel CACNA1H - Case Report

      hrp0086p1-p36
    • DNA Methylation Signatures Associated with Prenatal Dexamethasone Treatment

      hrp0086p1-p37
    • Twenty Years Experience in Congenital Adrenal Hyperplasia: Clinical, Hormonal and Molecular Characteristics in a Large Cohort

      hrp0086p1-p38
    • Chronic Adrenal Insufficiency Due to a Mutation of Nicotinamide Nucleotide Transhydrogenase 1 (NNT1): Case Report

      hrp0086p1-p39
    • Cognitive Functions in Congenital Adrenal Hyperplasia

      hrp0086p1-p40
    • RET and TP53 Concomitant Mutations: A Challenging Approach to a Unique Association of High Tumor Predisposing Conditions

      hrp0086p1-p41
    • Acute Lysis of a Giant Pediatric Adrenal Cortical Carcinoma Following One Dose of op'DDD

      hrp0086p1-p42
    • Severe Hypertension in a Girl: Cushing Syndrome or Apparent Mineralocorticoid Excess Syndrome? Utility of Molecular Study

      hrp0086p1-p43
    • An Infant with X-linked Adrenal Hypoplasia Congenita and Xp21 Contiguous Gene Deletion Syndrome

      hrp0086p1-p44
    • Polymorphisms Analyze in Gene CYP21A2 Gene Associated with Congenital Adrenal Hyperplasia

      hrp0086p1-p45
    • The Effect of Intrauterine Stress on Leukocyte Telomere Length in Newborns

      hrp0086p1-p46
    • Predictive Factors for Premature Pubarche in a Large Cohort of Italian Children

      hrp0086p1-p47
    • Cardiac Function in Pediatric Patients with Congenital Adrenal Hyperplasia

      hrp0086p1-p48
  • Adrenal P2
  • • Evaluation of the Combination of Anti-androgen and Anti-estrogen Treatment in Classical Congenital Adrenal Hyperplasia in Boys: Retrospective Study of 11 Cases

      hrp0086p2-p49
    • Ovarian Cysts in a 46,XX Patient with Congenital Lipoid Adrenal Hyperplasia and with Spontaneous Puberty

      hrp0086p2-p50
    • Bone Health Index in Children and Adolescents with Congenital Adrenal Hyperplasia

      hrp0086p2-p51
    • Occasional Detection of an Adrenal Incidentaloma in a Female Adolescent Evaluated for Cardiac Arrhythmias

      hrp0086p2-p52
    • Final Height in Congenital Adrenal Hyperplasia: A Retrospective Study

      hrp0086p2-p53
    • Hyperandrogenism in a 12-year Old Girl with a Congenital Porto-Systemic Shunt and Congenital Hepatic Fibrosis

      hrp0086p2-p54
    • The Treatment of a Functional Adrenocortical Cancer with Mitotane

      hrp0086p2-p55
    • The Effect of Anti-TNF on the Metabolism of Adrenal Hormones; A Steroid Metabolomic Approach

      hrp0086p2-p56
    • False-Positive Increases of Steroid Hormone Precursors Mimicking 11[beta]-Hydroxylase-Deficiency in a Preterm Infant

      hrp0086p2-p57
    • Isthmic Spondylolisthesis in a Pre-pubertal Boy with Congenital Adrenal Hyperplasia During Aromatase Inhibitor Treatment

      hrp0086p2-p58
    • Hospitalisation in Children with Adrenal Insufficiency and Hypopituitarism: Is there a Differential Burden Between Boys and Girls and Between Age Groups?

      hrp0086p2-p59
    • A Case of Cushing's Syndrome Due to Adrenocortical Adenoma with Pubarche and Obesity

      hrp0086p2-p60
    • Severe Neonatal Cushing Syndrome with Multi-Organ McCune Albright Manifestations

      hrp0086p2-p61
    • Final Height Data in a Cohort of Patients with Congenital Adrenal Hyperplasia Treated with Tailored Doses of Hydrocortisone

      hrp0086p2-p62
    • The Evolution of Bone Age in Girls with Premature Adrenarche

      hrp0086p2-p63
    • Cushing Syndrome Due to Adrenal Adenoma in an Adolescent Patient and Successful Treatment with Laparoscopic Surgery

      hrp0086p2-p64
    • A Novel Mutation of DAX-1 (NR0B1) in a Boy with X-linked Adrenal Hypoplasia Congenita

      hrp0086p2-p65
    • Clinical-Laboratory Findings of the Cases with Premature Pubarche and the Value of Acth Stimulation Test in the Differential Siagnosis

      hrp0086p2-p66
    • Successful Medical Management of Severe Neonatal Cushing Syndrome with Metyrapone, Guided by Mass Spectrometry Monitoring

      hrp0086p2-p67
    • Family Character Isolated Pheochromocytoma by Mutation in Vhl gen

      hrp0086p2-p68
    • Exaggerated Adrenarche and Exogenous Obesity: A Diagnostic Challenge

      hrp0086p2-p69
    • Vitamin D Insufficiency is Related to Premature Adrenarche

      hrp0086p2-p70
    • A Case of 17-Years-Old Boy with Relapsing Cushing Disease Presenting Vertebral Compression Fracture

      hrp0086p2-p71
    • The ımpact of 21 Hydroxylase Deficiency on Cardiac Repolarization Changes in Children with 21-hydroxylase-deficient Congenital Adrenal Hyperplasia

      hrp0086p2-p72
    • Patients with Congenital Adrenal Hyperplasia have Significantly Higher Healthcare Utilisation than the General Paediatric Population

      hrp0086p2-p73
    • Cholestasis and Hypercalcemia Secondary to Panhypopituitarism in a Newborn

      hrp0086p2-p74
    • Clinical Management in Secondary Pseudohypoaldosteronısm: A Case Series

      hrp0086p2-p75
    • High Sensitivity C-Reactive Protein (hsCRP) Levels as Predictor of Salivary Cortisol Acute Response to Mental Stress and/or Mobile Phone Call in Healthy Adolescents

      hrp0086p2-p76
    • Management Dilemmas in a Genetically Female Child with Congenital Adrenal Hyperplasia Raised as a Male

      hrp0086p2-p77
    • Primary Pigmented Nodular Adrenocortical Disease (PPNAD) Justifying a Pediatric Case of ACTH-independent Cushing Syndrome (CS)

      hrp0086p2-p78
    • Three Chinese Patients from Two Kindreds with Aldosterone Synthase Deficiency: Clinical Characteristic with Mutation Analysis Report

      hrp0086p2-p79
    • Addisonian Crisis Due to Autoimmune Adrenalitis in a 14 Year Old Boy with a History of Stem cell Transplantation (HSCT)

      hrp0086p2-p80
    • Assessment of Cardiac Function in Children Followed up for Congenital Adrenal Hyperplasia: A Case Control Study in Cameroon

      hrp0086p2-p81
    • A Novel Mutation of HSD3beta2 Presenting as Hypospadias with Salt-wasting in a Male Infant

      hrp0086p2-p82
    • Testicular Adrenal Rest Tumors in two Young Patients with Congenital Adrenal Hyperplasia

      hrp0086p2-p83
    • Hyperreninemic Hypoaldosteronism: Clinical and Genetic Features in Pediatric Patients

      hrp0086p2-p84
    • Peculiarities of Manifestation and Short-term Effects of Hormonotherapy in Children With Congenital Adrenal Cortical Hyperplasia

      hrp0086p2-p85
    • Congenital Adrenal Hyperplasia Revealed by Adrenal Nodules

      hrp0086p2-p86
    • Urosepsis or Pseudohypoaldosteronism in a Neonate?

      hrp0086p2-p87
    • A Case Report of Adrenocortical Adenoma in a Young Girl

      hrp0086p2-p88
    • Abstract unavailable

      hrp0086p2-p89
    • A Genetic Diagnosis of Familial Glucocorticoid Deficiency Resulting in Cessation of Long-term Mineralocorticoid Treatment in Three Siblings

      hrp0086p2-p90
    • Corticosteroid-Induced Adrenal Insufficiency in a Child with T Cell Lymphoblastic Lymphoma

      hrp0086p2-p91
    • A Rare Endocrine Association of Dilated Cardiomyopathy with Congenital Adrenal Hyperplasia due to 11 Beta Hydroxylase Deficiency

      hrp0086p2-p92
    • Use of an F-DEX Monocyte Binding Assay to Measure Steroid Responsiveness of Patients and their Related Donors Undergoing Stem Cell Transplant

      hrp0086p2-p93
    • 11[beta]- Hydroxylase Deficiency due to a Novel Compound Heterozygous Mutation and Literature Review

      hrp0086p2-p94
    • Early Adrenarche: A Common Query but not Easily Resolved

      hrp0086p2-p95
    • Assessment of Clinical Effectiveness and Safety of Using Flutamide in Children with Pre-menarche Hierperandrogenismo

      hrp0086p2-p96
    • Congenital Adrenal Hyperplasia - Subtle Presentations with Critical Electrolyte Imbalances and Cardiac Arrhythmias. Experiences from one Hospital

      hrp0086p2-p97
  • Bone & Mineral Metabolism P1
  • • Knock in of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-dependent Protein Kinase A Activation: A Model of Acrodysostosis Type 1?

      hrp0086p1-p98
    • Automated Greulich-Pyle Bone Age Determinations in Children with Chronic Endocrine Diseases

      hrp0086p1-p99
    • Cord 25-Hydroxyvitamin D and Infant Cranial Growth: An Odense Child Cohort Study

      hrp0086p1-p100
    • Effect of Bisphosphonates on Bone Fragility Due to Chronic Liver Disease in Ten Children

      hrp0086p1-p101
    • Radiologically Confirmed Fractures in a Scottish Nationwide Cohort of Boys with Duchenne Muscular Dystrophy

      hrp0086p1-p102
    • Monostotic Fibrous Dysplasia is a Single Disorder Caused by Somatic Mosaic Activating Mutations in GNAS

      hrp0086p1-p103
    • Clinically Significant Fracture Incidence in Czech Children: A Population-based Study

      hrp0086p1-p104
    • Effects of Selective GPER-1 Agonist G1 on Bone Growth

      hrp0086p1-p105
    • Bone Mineral Density, Pubertal Status and Ability to Walk are Associated to Fracture Incidence in Patients with Rett Syndrome

      hrp0086p1-p106
    • Bone Mineral Status in Children and Adolescents with Klinefelter Syndrome

      hrp0086p1-p107
    • Tolerability and Feasibility of Whole Body Vibration and its Effects on Muscle Function and Bone Health in Patients with Dystrophinopathy

      hrp0086p1-p108
    • Nonsense Mutation in SPARC Gene Causing Autosomal Recessive Ostegenesis Imperfecta

      hrp0086p1-p109
    • Increase in Sclerostin After Rapid Weight Loss in Children

      hrp0086p1-p110
    • Impact of Conventional Medical Treatment on Bone Mineral Density and Bone Turnover in Adult XLH Patients: A 6 Year Cohort Study

      hrp0086p1-p111
    • Bone Health and Body Composition in Childhood Onset Growth Hormone Deficiency at Time of Initial Evaluation and Retesting

      hrp0086p1-p112
    • Extension of The Bone Health Index to Adults, and Reference Curves of Four Indices of Cortical Bone for Healthy Europeans

      hrp0086p1-p113
    • Extension of Automated Bone Age Determination to the End of Puberty

      hrp0086p1-p114
    • A European Survey to Identify New Roads for Care, Training and Research Around Rare Metabolic Bone Diseases

      hrp0086p1-p115
    • Clinical and Molecular Characterization of 25-Hydroxylase Deficiency in Saudi Patients

      hrp0086p1-p116
    • No Severe Hypercalcemia During a 12-Month High-Dose Vitamin D Intervention in Infants

      hrp0086p1-p117
    • Management of Tracheobronchomalacia During Asfotase Alfa Treatment in Infants with Perinatal-onset Hypophosphatasia: A Case Series

      hrp0086p1-p118
    • Novel p.Asn628Ser Heterozygous Mutation in FGFR1 is Associated with Hartsfield Syndrome and Tumoral Calcinosis

      hrp0086p1-p119
    • Practicalities of Bisphosphonate use in UK Paediatric Tertiary Centres

      hrp0086p1-p120
    • Computer-assisted Diagnosis of Dyschondrosteosis Based on Skeletal X-ray Geometry

      hrp0086p1-p121
    • Bisphosphonates Therapy in Girls with Rett Syndrome and Bone Fragility

      hrp0086p1-p122
    • Skeletal Manifestations in APECED

      hrp0086p1-p123
    • Two French Families with Vitamin D Dependency Rickets Type 1B Harbor Homozygous Recessive Expression Of CYP2R1 Mutations L99P and G42_L46DEL INSR

      hrp0086p1-p124
    • Spectrum of the Genetic Defects in Hypophosphatemic Rickets in A Group of Turkish Children

      hrp0086p1-p125
    • Impact of Intercurrent Illness on Calcium Homeostasis and Hypoparathyroidism Management

      hrp0086p1-p126
    • Transient Pseudohypoaldosteronism and Failiure to Thrive in A 5-Month-Old Infant

      hrp0086p1-p127
    • Childhood Cancer Survivors (CCS) are at High Risk of Reduced Bone Mass During the Second Decade of Life

      hrp0086p1-p128
    • Trabecular Bone Score in Children from Mexico City: Preliminary Report

      hrp0086p1-p129
    • Triple X Syndrome: An Evaluation of Bone Mineral Status and Metabolism

      hrp0086p1-p130
    • Frequency of Recessive Osteogenesis Imperfecta in a Turkish Cohort and Genetic Causes

      hrp0086p1-p131
    • Spinal and Forearm Bone Mineralization in Adolescents with Klinefelter Syndrome

      hrp0086p1-p132
    • Treatment with Zoledronic Acid in Children with Duchenne Muscular Dystrophy

      hrp0086p1-p133
    • A RCT Comparing the Effect of Three Different Vitamin D Supplementation Regimens on Se 25 OH Vit D in Asymptomatic Vit D Deficient Children

      hrp0086p1-p134
    • Low Bone Mineral Density in Adolescents with Leukemia After Hematopoietic Stem Cell Transplantation

      hrp0086p1-p135
    • Growth Characteristics of a Girl with Multicentric Carpo-Tarsal Osteolysis Caused by Novel Mutation in the MAFB Gene

      hrp0086p1-p136
    • Treatment Experience and Long-Term Follow-Up Data in Two Severe Neonatal Hyperparathyroidism Cases

      hrp0086p1-p137
    • Biochemical Parameters Associated with Serum Intact FGF23 Levels in Patients with X-Linked Hypophosphatemic Rickets

      hrp0086p1-p138
    • Dental Effects of Intravenous Bisphosphonate When Administered in Early Infancy

      hrp0086p1-p139
    • Bone Mass and Vitamin D Status in Children and Adolescents with Generalized Epidermolysis Bullosa

      hrp0086p1-p140
    • Off-Label Use of the Aromatase Inhibitor Letrozole in Pubertal Boys to Improve Final Height: Laboratory, Auxological and Bone Age Data

      hrp0086p1-p141
    • Effect of Bisphosphonates and Denosumab on Trabecular Bone: Results of a Pilot Study in Children with Osteogenesis Imperfecta

      hrp0086p1-p142
    • Impact of Anti-Tumour Necrosis Factor Therapy on the Insulin Like Growth Factor Axis and Bone Development in Childhood Crohn's Disease

      hrp0086p1-p143
    • Effects of Phylloquinone and Magnesium on ATDC5 Prechondrocytes

      hrp0086p1-p144
    • To Study the Efficacy and Safety of Growth Hormone (GH) Therapy in Children with Pycnodysostosis

      hrp0086p1-p145
  • Bone & Mineral Metabolism P2
  • • Bone Mineral Status and Metabolism in Patients with Williams-Beuren Syndrome

      hrp0086p2-p146
    • The Beneficial Effect of Cinacalcet on the Treatment of vitD Resistant Rickets

      hrp0086p2-p147
    • A Preliminary Report on Body Composition Profile of Young Patients with Chronic Hemolytic Conditions

      hrp0086p2-p148
    • Bone Status in a Patient with IGF-I Receptor Deletion Syndrome: Bone Quality and Structure Evaluation Using DXA, pQCT, and QUS

      hrp0086p2-p149
    • Prevalence of Vitamin D Deficiency in Haitian Infants and Children

      hrp0086p2-p150
    • Progressive Development of PTH Resistance in Patients with Maternal GNAS Inactivating Mutations

      hrp0086p2-p151
    • Effect of Hydroxyurea Therapy on Growth Parameters in Older Children with Sickle Cell Disease

      hrp0086p2-p152
    • Evaluation of ALP Value in Early Prediction of the Effects of Growth Hormone Treatment in Children with Growth Hormone Deficiency (GHD)

      hrp0086p2-p153
    • Comparison of Two Different Stoss Therapy Doses in Children with Vitamin D Deficiency or Insufficiency without Rickets

      hrp0086p2-p154
    • Bisphosphonate Treatment of Hypercalcemia in a Child with Jansen'S Metaphyseal Chondrodysplasia

      hrp0086p2-p155
    • Physical Exercise Level is Associated to Peak Bone Mass in Undergraduate Students

      hrp0086p2-p156
    • A Case with Lethal Perinatal Hypophosphatasia

      hrp0086p2-p157
    • Anthropometric and Nutritional Parameters in Egyptian Children with Osteogenesis Imperfecta: Effect of Zoledronic Acid Therapy

      hrp0086p2-p158
    • Low Bone Mineral Density in Adolescents with Joint Hypermobility

      hrp0086p2-p159
    • Fractures in Children with Type 1 Diabetes are Associated with Poorer Bone Mineral Status and Glycaemic Control

      hrp0086p2-p160
    • Identification of Predictor Factors of Growth Outcome in Children with Hypophosphatemic Rickets

      hrp0086p2-p161
    • Effects of Socioeconomic Status on Bone Mineral Density and Vitamin D Concentrations in Healthy Female College Students

      hrp0086p2-p162
    • Bone Health Index is Low at Diagnosis of Growth Hormone Deficiency, and Improves During Growth Hormone Therapy

      hrp0086p2-p163
    • Vitamin D Dependent Rickets Type II in Saudi Children

      hrp0086p2-p164
    • Bone Health and Metabolic Syndrome in Childhood Cancer Survivors

      hrp0086p2-p165
    • Diversity in Phenotype of Two Siblings and their with X-Linked Hypophosphatemic Rickets due to PHEX Mutation

      hrp0086p2-p166
    • Expression of Brdu, VEGF, IGF-1R and Change of the Growth Plates from Sex Hormone-Inhibited Adolescents Rats - Pilot Study

      hrp0086p2-p167
    • A Case of Genetically Proven Carbonic Anhydrase II Deficiency

      hrp0086p2-p168
    • Rickets as Precocious Sign of Celiac Disease

      hrp0086p2-p169
    • Clinical and Genetic Analysis of Five Patients with Vitamin D-Dependent Rickets Type 1A

      hrp0086p2-p170
    • About a Case of a Family of Pycnodysostose

      hrp0086p2-p171
    • Potential Role of Vitamin D in Pathogenesis of Acute Rheumatic Fever

      hrp0086p2-p172
    • Bartter Syndrome with Bone-Destroying Hyperparathyroidism: About Two Cases, Genetically Proved, with Long-Lasting Follow-Up

      hrp0086p2-p173
    • Management of Hypoparathyroidism: Follow-Up of 20 Patients

      hrp0086p2-p174
    • Assessing the Serum Levels of Ferritin and Selenium in Three Important Infections of Childhood, Compared to a Control Group

      hrp0086p2-p175
    • A Case: Hydrocephalus Secondary to Suprasellar Arachnoid Cyst with Reset Osmostat and Isolated GH Deficiency

      hrp0086p2-p176
    • Cinacalcet Treatment in a Child with Concurrent Juvenile Idiopathic Arthritis and Hypocalciuric Hypercalcemia

      hrp0086p2-p177
    • Pseudohypoparathyroidism 1a with Turner's Syndrome: A Diagnostic Dilemma

      hrp0086p2-p178
    • Bisphosphonate Use for Control of Chronic Severe Bone Pain in Children with Malignancy Associated Bone Involvement

      hrp0086p2-p179
    • Renal Tubular Acidosis Causing Severe Growth Delay and Rickets in Two Siblings in Haiti

      hrp0086p2-p180
    • Pseudohypoparathyroidism Type IB Associated to Assisted Reproductive Technologies: Case Report

      hrp0086p2-p181
    • Primary Hyperparathyroidism- A Cause of Metabolic Syndrome in Children?

      hrp0086p2-p182
    • Hyperphosphatemic Familial Tumoral Calcinosis: Novel Indication to Sevelamer Carbonate

      hrp0086p2-p183
    • DiGeorge Syndrome and 10p Deletion

      hrp0086p2-p184
    • Multifocal Osteonecrosis after Short Term Methylprednysolon Therapy: A Case Report

      hrp0086p2-p185
    • Unclear Origin of Avascular Necrosis - Clinical Case

      hrp0086p2-p186
    • Is NOTCH-Sonic Hedgehog Signalling Pathway the Missing Link Between Hajdu-Cheney Syndrome and Syringomyelia?

      hrp0086p2-p187
    • The Unexpected Cause of Vitamin D Deficiency in a Resource Limited Setting: A Rare Case Report of Primary Intestinal Lymphangiectasia

      hrp0086p2-p188
    • About a Case of Dwarfism Idiopathic

      hrp0086p2-p189
  • Diabetes P1
  • • The Association of HLA Class II, CTLA-4 and PTPN22 Genetic Polymorphisms and [beta]-Cell Autoantibodies in Development of Type I Diabetes in Patients with Autoimmune Thyroid Disease

      hrp0086p1-p190
    • Insulin Pump Does Not Allow a Better Control than Injections in Childhood Type 1 Diabetes (T1d) in the ISIS-Diab Cohort

      hrp0086p1-p191
    • Diagnostic Features of Lipodystrophy in Children with Type 1 Diabetes

      hrp0086p1-p192
    • Recombinant Human Insulin-Like Growth Factor 1 (rh IGF1) Treatment of a Case of Leprechaunism: A Two and a Half Year Follow-Up

      hrp0086p1-p193
    • Longitudinal Monitoring of Pediatric Insulin Treatment in Germany and Austria: Age-Dependent Analysis of 63 967 Children and Adolescents with Type 1 Diabetes from the DPV Registry

      hrp0086p1-p194
    • Two Patients with HADH (SCHAD) Hyperinsulinism without Detectable 3-Hydroxybutyrylcarnitine/3-Hydroxyglutarate

      hrp0086p1-p195
    • Development of Type 1 Diabetes in a Child with Inherited CD59 Deficiency Treated with Eculizumab

      hrp0086p1-p196
    • Diagnosis of Non-Autoimmune Paediatric Diabetes by Targeted Next Generation Sequencing (NGS): Findings in Two Families with Rare Mono- and Digenic forms of Diabetes

      hrp0086p1-p197
    • Neonatal Siabetes, Gallbladder Agenesis and Cholestatic Giant Cell Hepatitis: A Novel Homozygote Mutation in PDX-1 Gene

      hrp0086p1-p198
    • Anthropometry and Glucose Homeostasis in a Patient with Donohue Syndrome (Homozygous Insulin Receptor Mutation): Effect of Continuous s.c. rIGF-I Therapy

      hrp0086p1-p199
    • Driving Paediatric Diabetes Care Forward in the UK: Improvements in Outcomes in the North West Following National Initiatives

      hrp0086p1-p200
    • Non-Surgical Treatment of Diazoxide-Resistant of Early Diffuse Hyperinsulinism Using Long-Acting Octreotide, A Somaatostatin Analog: Follow-Up of Six Cases

      hrp0086p1-p201
    • Screening for Autonomic Neuropathy in Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0086p1-p202
    • Diabetes Mellitus Caused by Bone Marrow Transplantation and Total Body Irradiation - Experience from a Regional Single Centre

      hrp0086p1-p203
    • A Syndrome of Permanent Neonatal Diabetes Mellitus and Neurological Abnormalities due to a Novel Homozygous Missense c.449T>A (p.I150N) Mutation in NEUROD1 Gene

      hrp0086p1-p204
    • Are We Screening Appropriate Age Group for Early Diagnosis of Cystic Fibrosis Related Diabetes in UK?

      hrp0086p1-p205
    • When to Screen for Coeliac Disease in Children with Type 1 Diabetes Mellitus: The Controversy

      hrp0086p1-p206
    • Interrelation between ACE Gene I/D Polymorphism and Chronic Kidney Disease Severity in Uzbek Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0086p1-p207
    • Improvement of Diabetic Screening System for School Children Achieved by Close Cooperation with a Local Government of Atsugi City

      hrp0086p1-p208
    • Association between Hypothalamus-Pituitary Adrenal Axis Activity and Anxiety in Prepubertal Children with Type 1 Diabetes

      hrp0086p1-p209
    • Screening for Liver Disease in Children and Adolescents with Type 1 Diabetes Mellitus: A Cross-sectional Analysis

      hrp0086p1-p210
    • Exploration of Social Network, Social Integration, and Socioeconomic Status in Families with Young Children with Type 1 Diabetes

      hrp0086p1-p211
    • Permanent Neonatal Diabetes Mellitus due to a Novel Homozygous GCK Mutation in a Premature Baby with IUGR and Its Management

      hrp0086p1-p212
    • The Impact of Diet on Insulin Dynamics over a 2-Year Period in Children with a Family History of Obesity

      hrp0086p1-p213
    • Analysis of Short-Term Efficacy of MiniMed 640G with SmartGuard in Pediatric Patients with Type 1 Diabetes

      hrp0086p1-p214
    • The Influence of sz-Cell Autoimmunity on Cystic Fibrosis Related Diabetes Mellitus - A DPV Registry Analysis

      hrp0086p1-p215
    • Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease Already at Diagnosis of Type 1 Diabetes

      hrp0086p1-p216
    • Hemolysis in a Girl with Type 1 Diabetes Mellitus and Glucose-6-Phosphate Dehydrogenase Deficiency

      hrp0086p1-p217
    • Clinical Characteristics and Molecular Analysis of Patients with Neonatal Diabetes

      hrp0086p1-p218
    • Impact of Continuous Glucose Monitoring System on Therapy of Cystic Fibrosis Related Diabetes in Children and Young Adults

      hrp0086p1-p219
    • Effect of Allopurinol Versus Angiotensin Converting Enzyme Inhibitors in Decreasing Microalbuminuria in Type 1 Diabetic Patients

      hrp0086p1-p220
    • Continuous Glucose Monitoring and Hypoglycemia Unawareness in Children and Adolescents with Type 1 Diabetes

      hrp0086p1-p221
    • Transient, Neonatal Hyperinsulinemic Hypoglycemia May be Monogenetic, Not Only Secondary to Fetal Life Events

      hrp0086p1-p222
    • The Relationship between the Serum Irisin Levels and the Metabolic Control in adolescents with Type 1 Diabetes

      hrp0086p1-p223
    • Space-time Environmental Associations in Childhood Type 1 Diabetes (T1D). A Case-control Geographical Approach in the ISIS-Diab Cohort

      hrp0086p1-p224
    • Association Between Vascular Endothelial Markers and Carotid Intima-media Thickness in Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0086p1-p225
    • Abstract unavailable

      hrp0086p1-p226
    • Rising of Type 1 Diabetes Mellitus Incidence in Chilean Children Between 2006 and 2014

      hrp0086p1-p227
    • Frequency and Risk Factors of Depression in Type 1 Diabetes in a Developing Country

      hrp0086p1-p228
    • Phenotypic Variability of Identical Mutations in the ABCC8 Gene in Two Families

      hrp0086p1-p229
    • Growth and Glucose Metabolism after Allogenic Bone Marrow Transplantation for Thalassemia Major

      hrp0086p1-p230
    • A Rare Form of Insulin Resistance with Pseudoacromegaly

      hrp0086p1-p231
    • Extrahepatic Biliary Atresia in Combination with Toxic Cholestasis Due to Glibenclamide in a Case of Neonatal Diabetes

      hrp0086p1-p232
    • Higher-Than-Conventional Subcutaneous Regular Insulin Doses Following Diabetic Ketoacidosis are Associated with Better Short-term Glycemic Control

      hrp0086p1-p233
    • Assessment of Selected Carbohydrate Parameters in Children Exposed to Gestational Diabetes in utero

      hrp0086p1-p234
    • The Genetic Causes and Phenotypic Characteristics of Egyptian Patients with Neonatal Diabetes Mellitus

      hrp0086p1-p235
    • Does Adherence to a High HbA1c Policy Improve Outcomes in a Paediatric Diabetic Clinic Population?

      hrp0086p1-p236
    • The Prevalence of Diabetic Ketoacidosis in Children with New-Onset Type 1 Diabetes Mellitus

      hrp0086p1-p237
    • Correction of Carnitine Deficiency in Children with Recent Onset Type 1 Diabetes

      hrp0086p1-p238
    • Fetal Growth Restriction Due to Maternal Congenital Hyperinsulinism Associated with a Novel Variant in GLUD1 and Intrauterine Diazoxide Exposure

      hrp0086p1-p239
    • Effect of Vitamin D Supplementation on Lipid Profile in Vitamin D Deficient T1D Patients with Dyslipidemia

      hrp0086p1-p240
    • Renal Functional Reserve in Children with Type 1 Diabetes

      hrp0086p1-p241
    • The Prognostic Role of Non-alcoholic Fatty Liver Disease in Children with Type 1 Diabetes Mellitus with and without Dyslipidemias

      hrp0086p1-p242
    • Associated and Familial Autoimmunity in Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0086p1-p243
    • Factors Affecting Dyslipidaemia in Children and Young People with Type 1 Diabetes Mellitus: A Multicentre Study

      hrp0086p1-p244
    • Abstract unavailable

      hrp0086p1-p245
    • Wolcott Rallison Syndrome due to a Novel Mutation in EIF2AK3 Gene

      hrp0086p1-p246
    • Which is the Best Site for Catheter Placement in Young Children with Type 1 Diabetes (T1D) and CSII?

      hrp0086p1-p247
    • GCK Mutations in Chinese MODY2 Patients: A Family Pedigree Report and Review of Chinese Literature

      hrp0086p1-p248
    • Autoimmune Limbic Encephalitis Associated with Type 1 Diabetes Mellitus

      hrp0086p1-p249
    • Type 1 Diabetes (T1D) Management with Few Blood Glucose (BG) Measurements but Frequent Free Adjustment of Treatment with Cell Phones or E-mails

      hrp0086p1-p250
    • Metabolic Impairments among Adult Survivors of Paediatric Abdominal and Pelvic Tumours in the St Jude Lifetime Cohort Study

      hrp0086p1-p251
    • Clinical Case of a 10-year-old Girl with Papillomatosis Due to Severe Insulin Resistance Type A

      hrp0086p1-p252
    • Sulphonylurea Treatment in a Patient with Intermediate DEND Syndrome

      hrp0086p1-p253
    • A Case-Control Search of Environmental (E) Factors for Childhood Type 1 Diabetes (T1D) Using Lifeline Questionnaires in the ISIS-Diab Cohort

      hrp0086p1-p254
    • Transient Neonatal Diabetes Mellitus in Hanoi, Vietnam: Clinical Feature and Outcome

      hrp0086p1-p255
    • The Incidence of Type 1 Diabetes in the Pediatric Population in Pomeranian Region in Poland

      hrp0086p1-p256
    • Health-Related Quality of Life and its Associated Factors in Children With Type 1 Diabetes Mellitus

      hrp0086p1-p257
    • Possible Monogenic Diabetes Mellitus Including Mody is Highly Prevalent in Korean Children with Diabetes Mellitus

      hrp0086p1-p258
    • Phenotype and Clinical Course of Diabetes Mellitus in Individuals with Pancreatic Hypoplasia Due to a PTFA Enhancer Mutation

      hrp0086p1-p259
    • Microalbuminuria in Type 1 Diabetes - Audit of Management of Children and Adolescents in a Single Diabetes Centre

      hrp0086p1-p260
    • Johansson-Blizzard Syndrome with Pan-hypopituitrism, Type 2 Diabetes and Pancreatic insufficiency: Effect of Treatment

      hrp0086p1-p261
  • Diabetes P2
  • • Comparison of the Occurrence of Islet Autoantibodies in Siblings of Patients with Type 1 Diabetes Mellitus to Healthy Children

      hrp0086p2-p262
    • The Role of 24-h Ambulatory Blood Pressure Monitoring in Children and Adolescents with Type 1 Diabetes: Early Experience of a Single Centre

      hrp0086p2-p263
    • Clinical, Biochemical, Genetic and Immunological Features of Mexican Recent-Onset Type 1 Diabetes Patients

      hrp0086p2-p264
    • Efficacy and Safety of Continuous Subcutaneous Insulin Infusion Treatment in Pre-schoolers. Long Term Experience of a Tertiary Care Centre in Spain

      hrp0086p2-p265
    • Gene-Environment (GxE) Interactions in Childhood Type 1 Diabetes (T1D): A Case-only Geographical Approach in the ISIS-Diab Cohort

      hrp0086p2-p266
    • NBAS Mutations, a New Monogenic Cause of DISOPHAL, a New Syndrome with Type 1 Diabetes (T1D)

      hrp0086p2-p267
    • A Patient with a Rare Monogenic Diabetes Syndrome

      hrp0086p2-p268
    • Which Group of Children Achieved the Best Results During Insulin Pump Therapy - Long-term Outcome in Children with Type 1 Diabetes?

      hrp0086p2-p269
    • Seasonality of Type 1 Diabetes in Children and Adolescents According to Date of Diagnosis and Date of Birth in a Large Diabetes Centre

      hrp0086p2-p270
    • Abnormal Glucose Level in Patients with Thalassemia Major

      hrp0086p2-p271
    • A Case Report of Wolfram Syndrome due to a Novel Homozygous Mutation in WFS1 Gene

      hrp0086p2-p272
    • Lower Basal Insulin Dose - Better Control in Type 1 Diabetes

      hrp0086p2-p273
    • 'Comparison of Neutrophil/Lymphocyte Ratio According to Degree of Glycemic Control in Children with Recent-onset Type 1 and Type 2 Diabetes

      hrp0086p2-p274
    • Pancreatic Reserve and Metabolic Control of Type 1 Diabetes in a Cohort of Spanish Children and Adolescent

      hrp0086p2-p275
    • The Best Practice Tariff for Paediatric Diabetes Care within England: A District General Experience

      hrp0086p2-p276
    • Prevalence of Cardiovascular Risk Factors and Obesity in Youth with Type 1 Diabetes in Lithuania

      hrp0086p2-p277
    • Childhood Type 1 Diabetes (T1D) Management with e-learning through Self-educational Tools

      hrp0086p2-p278
    • Mucormycosis and Type 1 Diabetes: A Case Report

      hrp0086p2-p279
    • Insulin Pump Therapy in Type 1 Diabetes: The Indian Experience

      hrp0086p2-p280
    • Child with Mutation in GATA 6 Gene - Case Report

      hrp0086p2-p281
    • A Case Report of a 14 Year Old Female with a Known History of Type 1 Diabetes Mellitus Who Developed Tracheal Stenosis as a Result of Prolonged Intubation from Diabetic Ketoacidosis and Subsequently Developed Acute Pancreatitis

      hrp0086p2-p282
    • Continuous Glucose Monitoring Can Alleviate Parental Fear of Hypoglycaemia in Children with Type 1 Diabetes Mellitus

      hrp0086p2-p283
    • The Implementation of a System of Continuous Monitoring of Blood Glucose and Open (FREE STYLE FREE) Improves Metabolic Control of Affected Children DMtipo1

      hrp0086p2-p284
    • Permanent Neonatal Diabetes by Gene Mutation KCNJ11. Evolution and Treatment after Three Years with Sulphonylureas

      hrp0086p2-p285
    • Atypical Cystic Fibrosis Adolescent Case Study (with Normal Sweat Test) Referring with Diabetes Mellitus Symptoms Found to Carry Homozygous R352Q Mutation

      hrp0086p2-p286
    • Diabetic Ketoacidosis Risk Factors in the Initial Presentation of Type 1 Diabetes Mellitus in Children and Adolescents

      hrp0086p2-p287
    • Prevalence of Polycystic Ovary Symdrome and its Clinical Profile in Young Females with Type 1 Diabetes Mellitus

      hrp0086p2-p288
    • The Frequency of Diabetic Ketoacidosis in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Single Centre Experience in Turkey

      hrp0086p2-p289
    • Wolcott-Rallison Syndrome: Clinical Case Presentation

      hrp0086p2-p290
    • The Story of a de novo Heterozygous HNF1A Mutation

      hrp0086p2-p291
    • Use of Continuous Glucose Monitoring Helps Selecting Insulin Therapy in Thalassemic Adolescents with Glycemic abnormalities

      hrp0086p2-p292
    • Impact of Demographic Factors on Diabetic Ketoacidosis Occurrence at Type 1 Diabetes Onset in Childhood

      hrp0086p2-p293
    • Differences in Hba1c among Different Ethnicities; Is it just a Matter of Mean Glycaemia?

      hrp0086p2-p294
    • Ischemic Intestinal Necrosis as a Rare Complication of Diabetic Ketoacidosis in a Child with New-Onset Type I Diabetes: A Case Report

      hrp0086p2-p295
    • Diabetes - a Rare Complication of Ataxic Telangiectasia Presenting in Childhood

      hrp0086p2-p296
    • Clinical and Demographic Characteristics of Patients with Type 1 Diabetes Mellitus and correlation with risk factors: A South Indian Database

      hrp0086p2-p297
    • Insulin Response at Standard Glucose Load in Children With Normal, Low and Excessive Body Mass

      hrp0086p2-p298
    • Initial Presentation of Subjects with Type 1 Diabetes: A Change in Spectrum

      hrp0086p2-p299
    • Evaluation of the Epidemiological, Presenting and Follow-up Characteristics and their Impacts on the Glycemic Control in a Large Cohort of Pediatric Type 1 Diabetes Mellitus Patients from Southeastern Anatolian Region of Turkey

      hrp0086p2-p300
    • HbA1C and IGF-1 Levels in Diabetic Children Treated with Vitamin D

      hrp0086p2-p301
    • Long-Term Follow-Up of Non-Diabetic Obese Children and Adolescents Treated with Metformin

      hrp0086p2-p302
    • Understanding the Molecular and Genetic Basis of Complex Syndromes of Diabetes Mellitus

      hrp0086p2-p303
    • Cardiovascular Risk and Long Term Follow-up of Turkish Children with Type 2 Diabetes: Single Center Experience

      hrp0086p2-p304
    • Thiamine Responsive Megaloblastic Anemia Due to SLCA19A2 Gene Mutation: Another Cause of Neonatal Diabetes with Succcesfull Switch from Insulin to Thiamine

      hrp0086p2-p305
    • Maturity-Onset Diabetes of the Young (MODY): Tracking and Clinical Follow-up

      hrp0086p2-p306
    • Evaluation of Autoimmune Thyroiditis Development on Onset and During Follow Up in Cases with Type 1 Diabetes Mellitus

      hrp0086p2-p307
    • The Autoimmune Hypothesis for Acute Bilateral Cataract in Type 1 Diabetes

      hrp0086p2-p308
    • Clinical Characteristics of Latent Autoimmune Diabetes in Youth (Type 1.5 DM)

      hrp0086p2-p309
    • Diabetic Ketoacidosis: Clinical Features and Precipitating Factors at DEMPU

      hrp0086p2-p310
    • Diabetes Distress in Adolescents and Young Adults with Type 1 Diabetes

      hrp0086p2-p311
    • A Novel Glucokinase Gen Mutation: Mody Type-2 Case

      hrp0086p2-p312
    • Congenital Hyperinsulinism in a Resource Limited Setting: Overcoming Barriers towards a Survival Path

      hrp0086p2-p313
    • Vitamin D Levels and Relations with Clinical and Laboratory Findings in Children with Newly Diagnosed Type 1 Diabetes

      hrp0086p2-p314
    • Lipid Profile, Lipid Per-Oxidation and Trace Elements Status in Libyan Males with Type II Diabetes Mellitus

      hrp0086p2-p315
    • Cystic Fibrosis Related Diabetes

      hrp0086p2-p316
    • Type 1 Diabetes in Childhood: An 8-year Experience

      hrp0086p2-p317
    • A Rare Reason of Type 2 Diabetes: Alstrom Syndrome

      hrp0086p2-p318
    • The Relationship among Cardiac T2*, Liver T2* and Abnormal Glucose in Patients with Thalassemia Major

      hrp0086p2-p319
    • Hyperglycaemia in a Boy of 13 years old: Not always Type 1 Diabetes Mellitus. A Case Report

      hrp0086p2-p320
    • Achievement of Metabolic Parameter Goals in Children and Adolescent with Type 1 Diabetes According to the Latest ADA/ISPAD Standards of Medical Care in Diabetes in a Pediatric Diabetes Clinic in North Greece

      hrp0086p2-p321
    • Clinical and Laboratory Characteristics of Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0086p2-p322
    • Prevalence of Acute Metabolic Complications in Children with Type I Diabetes Admitted to the Children Hospital in Qazvin, Iran (2005-2014)

      hrp0086p2-p323
    • Glargine versus Detemir Insulin During the Honeymoon Phase in a Child with Type1 Diabetes Mellitus

      hrp0086p2-p324
    • Diabetic Ketoacidosis and Multiple Organ Failure Syndrome: A Case Study

      hrp0086p2-p325
    • Neonatal Diabetes Associated with Transaminitis in a Growth Retarded Infant

      hrp0086p2-p326
    • Benefits of Switching Insulin from Twice Daily to Multiple Daily Injections on Glycaemic Control in Children with Type 1 Diabetes Mellitus in Sri Lanka at the Lady Ridgeway Hospital, Sri Lanka

      hrp0086p2-p327
    • Rapid Acting Insulin Analogue Treatment in Children and Adolescents with Type 1 Diabetes Mellitus; Insulin Glulisine Experience

      hrp0086p2-p328
    • The Prevalence of Dyslipidemia and Associated Factors in Children and Adolescent with Type I Diabetes

      hrp0086p2-p329
    • Lipid Metabolism in Children with Diabetes Mellitus Type 1

      hrp0086p2-p330
    • Prevalence of Celiac Disease in Children and Adolescents with Type 1 Diabetes Mellitus

      hrp0086p2-p331
    • Evaluating the Impact of the Diagnosis and Management of a Child with Type 1 Diabetes on Parents

      hrp0086p2-p332
    • Association Between Socioeconomic Status and Glycemic Control in Type 1 Diabetes Mellitus

      hrp0086p2-p333
    • Minimally Invasive Surgical Interventions in the Treatment of Primary Persistent Hyperinsulinemic Hypoglycemia of Infancy

      hrp0086p2-p334
  • Gonads & DSD P1
  • • Complete Androgen Insensitivity Syndrome Caused by a Deep Intronic Pseudoexon-Activating Mutation in the Androgen Receptor Gene

      hrp0086p1-p335
    • Polycystic Ovary Syndrome in Adolescence: New Therapeutic Approach with Inositol and Alpha-Lipoic Acid

      hrp0086p1-p336
    • 46,XY Partial Gonadal Dysgenesis Caused by an Xp21.2 Interstitial Duplication that Does not Encompass the NR0B1 Gene

      hrp0086p1-p337
    • Primary Ovarian Insufficiency in Childhood Cancer Survivors: A Report from the St Jude Lifetime Cohort (SJLIFE)

      hrp0086p1-p338
    • Global and Sexual Quality of Life in Patients with Rokitanski Syndrome: A Comparative Study Between Surgical vs Non Surgical Management of Vaginal Agenesis in a French Cohort of 130 Patients

      hrp0086p1-p339
    • Intrauterine Growth Restriction Affects Postnatal Testis Maturation in Rats

      hrp0086p1-p340
    • Application of on Line Learning in Assessment of Competencies of Fellows Pediatric Endocrinology

      hrp0086p1-p341
    • Genotype-phenotype Analysis of NR5A1/SF1 Mutations by Functional in vitro Studies

      hrp0086p1-p342
    • Evolution of Bone Mass and Body Composition in Gender Dysphoric Adolescents Treated with Progestins to Suppress Endogenous Hormones

      hrp0086p1-p343
    • Sertoli Cell Function During Chemotherapy in Pediatric Patients with Acute Lymphoblastic Leukemia

      hrp0086p1-p344
    • Accuracy of Pelvic MRI in Evaluating Internal Genitalia in Patients with Disorders of Sex Development

      hrp0086p1-p345
    • Using Public Databases, 'Virtual Controls' and Geolocalization to Search for Environmental Correlates of Hypospadias

      hrp0086p1-p346
    • The International AGD Consortium: A Multi-center Study of 3939 Infants and Children with Anogenital Distance Measurements

      hrp0086p1-p347
    • Exonic Splicing Mutations by Silent Nucleotide Variation in the Androgen Receptor Gene Causes Androgen Insensitivity Syndrome

      hrp0086p1-p348
    • Severe 5 Alpha Reductase 2 Deficiency with Aphallia is Caused by p.Y91H SRD5A2 Mutation and is Responsive to Dihydrotestosterone Administration During Childhood

      hrp0086p1-p349
    • Clinical History and High Prevalence of Gonadal Tumor in 14 Patients with 46 XY Pure Gonadal Dysgenesis

      hrp0086p1-p350
    • Abstract unavailable

      hrp0086p1-p351
    • A Multicenter Study on Long-Term Outcomes in 56 Males with 45,X/46,XY Mosaicism

      hrp0086p1-p352
    • Familial Testotoxicosis: Outcome and Possible Relation to Testicular Malignancies

      hrp0086p1-p353
    • Psychological Impact in Young Women of Announcement of a Utero-Vaginal Malformation (Mayer-Rokitansky-Kuster-Hauser - MRKH Syndrome) and its Treatment

      hrp0086p1-p354
    • Mutations at the SF-1 Ligand-Binding Domain Can Lead to Different Effects on DNA Binding: Report of Two Novel Mutations

      hrp0086p1-p355
    • A New International Registry Highlights the Differences in Practice for Reaching a Diagnosis of CAH - On Behalf of the I-CAH/I-DSD Registry User Group

      hrp0086p1-p356
    • Changes in Adrenal Steroids During Puberty Suppression and Cross Sex Hormone Treatment in Gender Dysphoric Adolescents

      hrp0086p1-p357
    • Do the Anti-Mullerian Hormone Levels of Adolescents with Polycystic Ovarian Syndrome (PCOS), Those Who Are at Risk for Developing PCOS, and Those Who Exhibit Isolated Oligomenorrhea Differ from those of Adolescents with Normal Menstrual Cycles?

      hrp0086p1-p358
    • Feasibility Study for Avoiding Early Surgery in Girls with 21-Hydroxylase Deficiency (21OHD)

      hrp0086p1-p359
    • A Novel Familial Androgen Receptor Mutation (W752G) in Complete Androgen Insensitivity Syndrome: Use of in vitro Study According to the Nature of Amino Acid Substitution

      hrp0086p1-p360
    • Partial and Mixed Gonadal Dysgenesis Cannot be Distinguished by Histological Picture: Clinical Evaluation, Histological Differences and Long-Term Follow up of 61 Brazilian Patients

      hrp0086p1-p361
    • Aromatase Activity is Disrupted by Mutations in P450 Oxidoreductase

      hrp0086p1-p362
    • Mosaic Xq Partial Duplication Leading to Virilisation of an Adolescent Female

      hrp0086p1-p363
    • Genotyping Patients with Differences of Sex Development: 25 Years of Investigation of an Italian Population of 308 Cases (194 46,XY and 114 46,XX)

      hrp0086p1-p364
    • Functional Studies of a New Mutation in the LH/CG Receptor Gene Identified in 2 Sisters with 46,XY DSD

      hrp0086p1-p365
    • Consecutive Lynestrenol and Cross-Sex Hormone Treatment in Biological Female Adolescents with Gender Dysphoria: A Retrospective Analysis

      hrp0086p1-p366
    • Ovarian Reserve Assessment in Girls and Women after Hematopoietic Stem Cell Transplantation Treatment Underwent in Childhood

      hrp0086p1-p367
    • Precocious/Early and Accelerated Puberty in a Boy with a Homozygous R192C Mutation in CYP19 (Aromatase) Gene

      hrp0086p1-p368
    • Long-Term Follow-Up of Patients with 46,XY Partial Gonadal Dysgenesis Accordingly Gender Assignment

      hrp0086p1-p369
    • 45,X/46,XY Chromosomal Disorders of Sex Development: Experience from a Cohort of 50 Patients Followed in One Single Institution

      hrp0086p1-p370
    • Androgen Profile Differs to Adults in Adolescent Girls with Polycystic Ovary Syndrome

      hrp0086p1-p371
    • Effects and Side Effects of Cyproterone Acetate Alone and in Combination with Estrogens in Natal Male Adolescents with Gender Dysphoria

      hrp0086p1-p372
    • Compound Heterozygous C10orf2 Mutations in a Japanese Patient with 46,XX Ovarian Failure and Deafness

      hrp0086p1-p373
    • GATA Transcription Factors in Testicular Adrenal Rest Tumours

      hrp0086p1-p374
    • Can we Standardize Sex Assignment in 45,X/46,XY Mixed Gonadal Dysgenesis?

      hrp0086p1-p375
    • Intratubular Large Cell Hyalinizing Sertoli Cell Tumor of the Testis Presenting with Prepubertal Gynecomastia: A Case Report

      hrp0086p1-p376
    • Effect and Safety Aspects of Percutaneous Administration of Dihydrotestosterone in Children with Micropenis with Different Genetic Background

      hrp0086p1-p377
    • Randomized Controlled Study Comparing Vitamin D and Omega 3-Fatty Acids Supplementation in Adolescents with Polycystic Ovary Syndrome

      hrp0086p1-p378
    • Health-Related Quality of Life and Psychological Wellbeing in Adults with Diverse Sex Development

      hrp0086p1-p379
    • Association of Genetic Polymorphisms Around the LIN28B Gene and Idiopathic Central Precocious Puberty Risks Among Chinese Girls

      hrp0086p1-p380
    • Psychological Outcomes and Quality of Life of Patients with Non-CAH DSD

      hrp0086p1-p381
    • Normalization of Ovulation Rate in Adolescent Girls with Hyperinsulinemic Androgen Excess

      hrp0086p1-p382
  • Gonads & DSD P2
  • • Thyroid Autoimmunity in Adolescent Girls with Polycystic Ovary Syndrome - Pilot Study

      hrp0086p2-p383
    • The Efficacy and Safety of Gonadotropin-Releasing Hormone Analogue Treatment to Suppress Puberty in Gender Dysphoric Adolescents

      hrp0086p2-p384
    • A Familial form of DSD due to NR5A1 Mutation in a Father and His Son

      hrp0086p2-p385
    • High Prevalence of SGA in Patients with Disorders of Sexual Development, Especially Idiopathic 46,XY DSD

      hrp0086p2-p386
    • Questionnaire Surveys Targeting Japanese Pediatric Endocrinologists Regarding Reproduction in Pediatric and Adolescent Cancer Patients

      hrp0086p2-p387
    • Fertility Outcomes after Childhood Onset Hypothalamic Hypogonadism

      hrp0086p2-p388
    • Persistent Mullerian Duct Syndrome with Transverse Testicular Ectopia: A Novel AMH Receptor Mutation

      hrp0086p2-p389
    • Three Cases of NR5A1 (SF1) Gene Mutations in DSD Patients

      hrp0086p2-p390
    • Sertoli-Leydig Cell Tumor as a Rare Cause of Hirsutism in a Young Adolescent

      hrp0086p2-p391
    • Identification of an AR Mutation in Klinefelter's Syndrome during Evaluation for Penoscrotal Hypospadias

      hrp0086p2-p392
    • Assessment of Sexual Identity in Patients with Congenital Adrenal Hyperplasia

      hrp0086p2-p393
    • Duct Ectasia, a Rare Complication of Gynaecomastia

      hrp0086p2-p394
    • Evaluation of Anti-Mullerian Hormone (AMH) Assay Roche® on Umbilical Cord Blood: Determination of Reference Values in Girls and Boys Newborn

      hrp0086p2-p395
    • Hypogonadotropic Hypogonadism in a Girl with 2p11.2-2q12.1 Duplication

      hrp0086p2-p396
    • A Nonvirilized form of Classic 3[beta]-Hydroxysteroid Dehydrogenase Deficiency Due to a Homozygous S218P Mutation in the HSD3B2 Gene in a Girl with Classic Phenylketonuria

      hrp0086p2-p397
    • Nonclassic Congenital Adrenal Hyperplasia and Functional Ovarian Hyperandrogenism Diagnosed During the Transition Period: Differences in Clinical, Hormonal and Metabolic Aspects

      hrp0086p2-p398
    • Diagnosis of PCOS in Adolescents Using MRI

      hrp0086p2-p399
    • Novel CYP17A1 Mutation and CYP21 Mutations in Two Siblings

      hrp0086p2-p400
    • Aetiology of 46,XY DSD in Algeria; Putative Modifier Role of pV89L Polymorphism in the SRD5A2 Gene in Androgen Receptor Mutation-Negative Subjects

      hrp0086p2-p401
    • Children with 46,XY DSD: Etiology, Clinical Profile, Socio-Demographic Details and Sex of Rearing

      hrp0086p2-p402
    • Endocrine Risk Factors of Testicular Cancer of Children and Teenagers with Testicular Microlithiasis

      hrp0086p2-p403
    • Case Report of a Girl with Secondary Amenorrhea Associated with Aurantiasis Cutis

      hrp0086p2-p404
    • Maternal Ovarian Luteoma Causing Complete Virilization of a Female Fetus

      hrp0086p2-p405
    • The Experience of GAIA (Abuse Childhood and Adolescence Group) - AOU Meyer

      hrp0086p2-p406
    • State of Knowledge of Late Endocrinological Effects of Hematological Patients Who Has Undergone Chemotherapy

      hrp0086p2-p407
    • Disorders of Sex Genitalia in Yaounde: Difficult Questions, Which Answers?

      hrp0086p2-p408
    • Analysis of Clinical Manifestations and Gene Mutations of 5[alpha]-Reductase Type 2 Deficiency in 16 Cases

      hrp0086p2-p409
    • Unusual Differential Diagnosis of Hyperandrogenism in Adolescent Female Treated for Polycystic Ovarian Syndrome

      hrp0086p2-p410
    • Phenotypic and Hormonal Variability in 46,XY Subjects with SF-1 Mutations

      hrp0086p2-p411
    • Towards the Roles of Kisspeptins in the Control of Gonadotropic Axis: Focus on Peripheral Signaling in Androgen-Dependent Tissues in the Experimentally Induced Model Hypogonadotropic Hypogonadism in Male Rats

      hrp0086p2-p412
    • Two Patients Presenting the Extremes of the Phenotypic Spectrum of 5 alfa Reductase Deficiency: One with at New Mutation

      hrp0086p2-p413
    • Disorders of Sex Development 45,X/46,XY: Clinical and Laboratory Characteristics of Patients

      hrp0086p2-p414
    • Reproductive Function of Central Precocious Puberty in Girls: A Systematic Review

      hrp0086p2-p415
    • Cytogenetic Variability and Phenotypic Findings in Patients with Ovotesticular Disorder of Sex development

      hrp0086p2-p416
    • Cytogenetic Study of Sex Chromosomal Abnormalities in Egyptian DSD Patients

      hrp0086p2-p417
    • Phenotype, Genotype and Gender Identity in Pubertal and Post-Pubertal Patients with Androgen Insensitivity Syndrome

      hrp0086p2-p418
    • XLAG Syndrome Case Accompanying a New ARX Mutation and has a Interhemispheric Cyst

      hrp0086p2-p419
    • Congenital Adrenal Lipoid Hyperplasia in a 30-Year-Old Female with a Tall Stature

      hrp0086p2-p420
    • Onset of Puberty in Healthy Boys is Associated with a Decreased BMI Compared to Values Prior to the Onset of Puberty

      hrp0086p2-p421
    • Late Clinical Presentation, Biological Assessment and Management of PAIS in a Developing Country

      hrp0086p2-p422
    • Sisters with 46XY Gonadal Dysgenesis and Gonadoblastoma

      hrp0086p2-p423
    • Follow-up to Adulthood of Two 46,XY Siblings with 5-alpha Reductase Deficiency and Different Sex of Rearing

      hrp0086p2-p424
    • Constitutional Delay of Puberty: Clinical and Hormonal Characteristics of Patients

      hrp0086p2-p425
    • Comparison between Serum Vitamin D Levels in Precocious Pubertal Girls and Normal Girls

      hrp0086p2-p426
    • Complete Virilization without Salt Wasting in a 7-year-old Haitian Child with Congenital Adrenal Hyperplasia

      hrp0086p2-p427
    • Hematocolpos Revealed by Non-cyclic Lower-back Pain in a Pre-menarcheal Girl

      hrp0086p2-p428
    • Novel AMH and AMHR-II Mutations in Two Egyptian Families with Persistent Mullerian Duct Syndrome

      hrp0086p2-p429
    • Study of Genetics of Human Disorders of Sexual Development. Research Project.

      hrp0086p2-p430
    • 46XX Male Syndrome

      hrp0086p2-p431
    • 45,X/47,XYY Chromosomal Mosaicism as a Cause of 46,XY Disorder of Sex Development

      hrp0086p2-p432
    • 46,XY Complete Gonadal Dysgenesis with Late Diagnosis

      hrp0086p2-p433
    • Diagnosis, Treatment and Gene Mutation Analysis of the Case with Steroid 5[alpha]-Reductase Type 2 Deficiency

      hrp0086p2-p434
    • An Infant with 49XXXXY Syndrome: A Case Report from Sri Lanka

      hrp0086p2-p435
    • Mixed Gonadal Disgenesia: Patients of Instituto da Crianca, HC-FMUSP

      hrp0086p2-p436
    • Primary Amenorrhea as Alarm Manifestation in a Oligosymptomatic Girl with Xq Deletion and Turner Syndrome

      hrp0086p2-p437
    • Hypogonadotropic Hypogonadism in a Patient with Vanishing Testis Syndrome - Case Report

      hrp0086p2-p438
    • 17 Alpha Hydroxylase, 17-20 Lyase Deficiency, a Case with Hypocalcemic Symptoms

      hrp0086p2-p439
    • An Uncommon Case of Adolescent with POF

      hrp0086p2-p440
    • Trisomy 9 Syndrome in an Infant with Ambiguous Genitalia

      hrp0086p2-p441
  • Fat Metabolism and Obesity P1
  • • Placental and Cord Blood DNA Methylation Profiling in Small-for-Gestational-Age Newborns from Uncomplicated Pregnancies: Relationship to Prenatal Growth and Postnatal Body Composition

      hrp0086p1-p442
    • The Collapse of the BDNF/POMC System in the Hypothalamus is Responsible for the Extreme Obesity with Hyperphagia Observed in Female Heterozygous MeCP2 Null Mice

      hrp0086p1-p443
    • Neonatal Overfeeding Alters Hepatic Insulin Sensitivity During Lactation and Leads to Long-term Insulin Resistance and Fatty Liver in Mice: Key Role of Mogat1

      hrp0086p1-p444
    • The Impact of Activating PIK3CA Mutations and PTEN Haploinsufficiency on Human Adipocyte Phenotype and Biology

      hrp0086p1-p445
    • Bioinactive Leptin is not Frequently Detected in Severe Early Onset Childhood Obesity

      hrp0086p1-p446
    • Neonatal Overnutrition Causes Sex and Age Dependant Long-Term Effects on Body Weight, Body Composition and Serum Triglyceride and Free Fatty Acid Levels

      hrp0086p1-p447
    • Laparoscopic sleeve gastrectomy in adolescents with morbid and dynamic obesity. A controlled monocentric study.

      hrp0086p1-p448
    • Efficacy, Safety and Metabolic Effects of Carbohydrate Restriction in the Treatment of Obese Adolescents

      hrp0086p1-p449
    • Severe Hypertriglyceridemia in Pediatric Oncology Patient

      hrp0086p1-p450
    • The Frequencies of 5-HTTLPR Locus in Promotor Part of Serotonine Transporter Gene (SLC6A4) Polymorphism in Children with Different Forms of Obesity

      hrp0086p1-p451
    • High Predictability of Impaired Glucose Tolerance by Combining Diagnostic Parameters in Obese Children

      hrp0086p1-p452
    • The Effect of Subclinical Hypothyroidism (SH) and Treatment of SH with L-T4 on Basal Metabolic Rate in Obese Children: A Prospective Study

      hrp0086p1-p453
    • Influence of Television Viewing During Meals on Eating Patterns

      hrp0086p1-p454
    • Seven-year Follow-up of Mothers from a Randomized Controlled Trial of Exercise in Pregnancy and their Offspring

      hrp0086p1-p455
    • E-Health: A National Registry and Therapeutic Algorithm for the Prevention and Management of Overweight and Obesity in Childhood and Adolescence in Greece

      hrp0086p1-p456
    • Premature Adrenarche and Metabolic Risk: Differences by Gender

      hrp0086p1-p457
    • Association of miR-34a and mir-149 with Obesity and Insulin Resistance in Obese Children and Adolescents

      hrp0086p1-p458
    • Erythropoietin Activates Classical Brown Adipose Tissue Through the Erythropoietin Receptor/STAT3 Pathway, Improving Obesity and Glucose Homeostasis in High Fat Diet-induced Obese Mice

      hrp0086p1-p459
    • The Association between Insulin Resistance and Lower Extremity Muscle Strength, Static and Dynamic Standing Balances in Obese Adolescents

      hrp0086p1-p460
    • Adiponectin and IL-6 in Simple Childhood Obesity with and without Hepatic Steatosis

      hrp0086p1-p461
    • Determinants of Advanced Bone Age in Childhood Obesity

      hrp0086p1-p462
    • Exposure to Phthalates Is Associated with Overweight or Obesity in 4-Year-Old Children

      hrp0086p1-p463
    • Central Obesity among European Preschool Children: The ToyBox-Study

      hrp0086p1-p464
    • Changes in Waist-to-Height Ratio during Preschool Years Differ between Children being Obese or Overweight at Five Years of Age Compared with not Overweight Children

      hrp0086p1-p465
    • Remarkable Increase in the Prevalence of Overweight and Obesity among School Age Children in Antalya, Turkey, between 2003 and 2015

      hrp0086p1-p466
    • The Peculiarities of Neurotransmitters Levels in Children with Obesity and Different Genotypes of COMT Gene

      hrp0086p1-p467
    • Association of Fasting Triglycerides to High-Density Lipoprotein Ratio with Risk for Metabolic Disorders in Children

      hrp0086p1-p468
    • Assessment of Adherence to Mediterranean Diet during a Weight Loss Intervention in Children with Cardiometabolic Risk

      hrp0086p1-p469
    • Brain Structure, Executive Function and Appetitive Traits in Adolescent Obesity

      hrp0086p1-p470
    • Improved Clinical and Laboratory Changes after 12 Months of Use of Metformin in Obese Insulin Resistant Children and Adolescents

      hrp0086p1-p471
    • Risk factors for Atherosclerosis after Anticancer Treatment in Childhood: The Assessment of Lipid Parameters and Indicators of Susceptibility to Atherosclerosis in a Group of Pediatric Patients after Anticancer Treatment

      hrp0086p1-p472
    • Inherited Duplication (X) (p11.4) Associated with Obesity, Autoaggressive Behaviour and Delayed Speech Development

      hrp0086p1-p473
    • Switching Patients with Congenital Hyperinsulinism from Standard Octreotide to Long-Acting Release Octreotide Preserves Blood Glucose Control and Improves Quality of Life of Their Caregivers

      hrp0086p1-p474
    • Reduction of Body Mass and Change in Body Composition of the Participants of the PoZdro! - Programme for Prevention of Diabetes and Civilisation Diseases by Medicover Foundation - Preliminary Results, after the First Year of Interventions

      hrp0086p1-p475
    • Polysomnography in Obese Children with and without Prader-Willi

      hrp0086p1-p476
    • Renal Involvement ın Obese Children and Adolescents

      hrp0086p1-p477
    • BMI Correlates Positively with Hair Cortisol, whereas Excessive Body Fat Correlates Positively with Hair Cortisol: Salivary Cortisol and Fasting Insulin Concentrations in Prepubertal Girls

      hrp0086p1-p478
    • Hepatic Steatosis and Cardiovascular Risk in Overweight Children: Preliminary Results of the Study EFIGRO

      hrp0086p1-p479
    • Associations of Different Appetite Hormones with Physical Activity and Cardiorespiratory Fitness in Adolescent Boys with Different BMI Values

      hrp0086p1-p480
    • The Relation of Glycaemic Variability Obtained by Continuous Subcutaneous Glucose Monitoring with IL-6 and Adiponectin Levels in Obese Children with Metabolic Syndrome and Insulin Resistance

      hrp0086p1-p481
    • Changes in Urine and Plasma Metabolomics Profiles after a Lifestyle Intervention Program in Obese Prepubertal Children

      hrp0086p1-p482
    • The Effectiveness of a Stress Management Intervention Program in the Management of Overweight and Obesity in Childhood and Adolescence

      hrp0086p1-p483
    • Fetuin-A as an Alternative Marker for Insulin Resistance and Cardiovascular Risk in Prepubertal Children

      hrp0086p1-p484
    • What are Early Predictors of Impaired Glucose Tolerance in Children Born SGA?

      hrp0086p1-p485
    • Multidisciplinary Intervention Programme in Childhood Obesity- Review of Service

      hrp0086p1-p486
    • Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report

      hrp0086p1-p487
    • Glucose Metabolism In Children with Prader-Willi Syndrome: The Effect Of Gh Therapy

      hrp0086p1-p488
    • Impact of a Group-based Treatment Program on Adipocytokines, Oxidative status, Inflammatory Cytokines, and Pulse Wave Velocity in Obese Children and Adolescents

      hrp0086p1-p489
  • Fat Metabolism and Obesity P2
  • • Matsuda Index in Correlation with Clinical Indicators of Insulin Resistance in Children and Adolescents

      hrp0086p2-p490
    • Anthropometric, Biological and Imagistical Methods For Assessing the Cardiovascular Risk in Obese Children

      hrp0086p2-p491
    • Trends of Nutrition of Ukrainian Children from Kharkiv Region: Tendency to Overweight, Dehydration, Impaired Social Adaptation

      hrp0086p2-p492
    • Melanocortin-4 Receptor Gene Mutations in a Group of Turkish Obese Children and Adolescents

      hrp0086p2-p493
    • Comparison between CDC (Centers for Disease Control and Prevention) and Italian Growth Charts in the Characterization of Pediatric Obesity

      hrp0086p2-p494
    • The Cutoff Values of Indirect Indices for Measuring Insulin Resistance in Korean Children and Adolescents

      hrp0086p2-p495
    • Intensive Exercise Intervention for Long-term Adolescent and Young Adult Survivors of Oncology-Related Cranial Insult: A Pilot Study

      hrp0086p2-p496
    • Cardiometabolic Effect of Sugar-Sweetened Beverages Reduction in Obese Children

      hrp0086p2-p497
    • A Comprehensive and Multidisciplinary Management Plan is Extremely Effective at Reducing the Prevalence of Overweight and Obesity in Childhood and Adolescence

      hrp0086p2-p498
    • Multidisciplinary Care Management of Pediatric Obesity and Factors Associated with Better Outcomes

      hrp0086p2-p499
    • Prevalence and Characteristics of Polycystic Ovary Syndrome in Obese Adolescents

      hrp0086p2-p500
    • Efficacy of the Treatment for Childhood Obesity in Specialist Care: Age Over 10 Years at Baseline and Acanthosis Nigricans Predict a Worse Outcome

      hrp0086p2-p501
    • Metabolic Syndrome in Prepubertal Obese Children: Inclusion of the Triglyceride/Hdl Ratio as an Alternative Diagnostic Criterion

      hrp0086p2-p502
    • The relationship between Subclinical Hypothyroidism and Iodine Deficiency, Serum Leptin Levels and Metabolic Syndrome in Obese Children

      hrp0086p2-p503
    • Analysis of Circulating miRNAs in Obese Children Born Small for Gestational Age

      hrp0086p2-p504
    • Irisin and Abdominal Obesity in Preschool Age

      hrp0086p2-p505
    • Long Term Outcomes after Hospital Based, Life-Style Weight Loss Intervention During Childhood

      hrp0086p2-p506
    • Implications of Insulin Resistance in Obese and Overweight Children: A Cohort Analysis

      hrp0086p2-p507
    • Effects of Highly Mineralized Water on Weight and Metabolism - A Randomized Controlled Blinded Trial in a Pediatric Hospital Staff

      hrp0086p2-p508
    • Which Marker is the Most Reliable One for the Detection of NAFLD in Outpatient Clinic?

      hrp0086p2-p509
    • Nonalcoholic Fatty Liver Disease: Evolution after 1 year of Follow-Up with Different Therapies

      hrp0086p2-p510
    • Lifestyle Survey of Doctors, Medical Residents and Medical Students in Latvia

      hrp0086p2-p511
    • Weight Status in Children at 8 Years: A Prospective Cohort Study

      hrp0086p2-p512
    • Low Birth Weight is not Associated with Increased Risk of Metabolic Syndrome in Obese Children and Adolescents

      hrp0086p2-p513
    • Prader Willi Syndrome in Brazil: 6 months Follow-up in a Reference Center

      hrp0086p2-p514
    • Early Blood Pressure Abnormalities Related to Cardiovascular Risk in Obese Children and Adolescents

      hrp0086p2-p515
    • 4G Polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1), PAI-1 Plasma Levels, and Lipid Profiles in Overweight/Obese Children and Adolescents

      hrp0086p2-p516
    • Polycystic Ovarian Syndrome in a Population of Obese Adolescents

      hrp0086p2-p517
    • Vitamin D Deficiency in Obese Children and the Relationship with Insulin Resistance and Metabolic Syndrome

      hrp0086p2-p518
    • Dietary Habits of Children and Adolescents Attending an Out-Patient Clinic for the Prevention and Management of Overweight and Obesity in Greece

      hrp0086p2-p519
    • Preliminary Findings on Nutrition Care Competence in Health Care Professionals Using a Standardized Questionnaire NUTCOMP Korean Version

      hrp0086p2-p520
    • Construction of Remote Monitoring System of Children with Tall or Short Stature and Overweight or Poor Weight Gain from the Elementary School Health Checkup Data

      hrp0086p2-p521
    • The Effect of Demographic and Lifestyle Factors on One-year BMI Increments in 776 Norwegian Children Aged 6-15 Years

      hrp0086p2-p522
    • Body Image Perception Changes in Obese and Lean Children

      hrp0086p2-p523
    • Non-Alcoholic Hepatic Steatosis in Obese Children and the Relationship with Insulin Resistance

      hrp0086p2-p524
    • Prevalence of Melanocortin 4 Receptor Mutations in Turkish Obese Children

      hrp0086p2-p525
    • Prevalence of Overweight and Obesity in Children and Adolescents in Izmir, Western Turkey

      hrp0086p2-p526
    • Arbitrary Cutoffs Lead to Underestimation of Metabolic Abnormalities in Obese Children: The Value of Age- and Sex-adjusted Normative Values

      hrp0086p2-p527
    • Breasts Diseases in Adolescent Girls With Obesity

      hrp0086p2-p528
    • Insulin Resistance Correlates to Cognitive Fatigue Dimensions in Non-diabetic Obese Children

      hrp0086p2-p529
    • Vascular Endothelial Growth Factor as The Predictor Microangiopathy in Obese and Diabetic Children

      hrp0086p2-p530
    • Associations of Serum 25-Hydroxyvitamin D and Components of the Metabolic Syndrome in an Egyptian Cohort

      hrp0086p2-p531
    • Retrospective Evaluation of the Efficiency of Metformin Therapy in Obese Children with Insulin Resistance

      hrp0086p2-p532
    • Parental Obesity can Trigger Obesity in Children

      hrp0086p2-p533
    • Value of BMI-SDS, Waist Circumference-SDS and Waist-to-Height Ratio in the Identification of Obese Children and Adolescents at an Increased Risk for Cardio-Metabolic Complications

      hrp0086p2-p534
    • Thyroid Dysfunction and Formation of Dyslipoproteiniaemias: Gender Differences in Children with Obesity

      hrp0086p2-p535
    • How Early is Insulin Resistance in Our Pediatric Population with Metabolic Syndrome

      hrp0086p2-p536
    • Insulin Resistance for Adolescents with Obesity in Latvia

      hrp0086p2-p537
    • Parental Obesity can Trigger Obesity in Children

      hrp0086p2-p538
    • Cerebrotendinous Xanthomatosis: A Case Report of Rare Lipid Storage Disorder

      hrp0086p2-p539
    • Analysing Child Obesity Risk Factors: Adenotonsillectomy

      hrp0086p2-p540
    • Non-Medicament Treatment of Severe Obese Children, Using the One-Year Courses

      hrp0086p2-p541
    • Obstructive Sleep Apnea Syndrome in Early Childhood: Case Report

      hrp0086p2-p542
    • 25-Hydroxyvitamin D Concentrations in Pubertal Children with Obesity

      hrp0086p2-p543
    • Management Preschool Children of Prader-Willi Syndrome

      hrp0086p2-p544
    • Prevalence of Acanthosis Nigricans and Related Factors in Iranian Obese Children

      hrp0086p2-p545
  • Perinatal Endocrinology P1
  • • Higher Risk of Low Birth Weight and Multiple Nutritional Deficiencies in Neonates from Mothers after Gastric Bypass: A Case Control Study

      hrp0086p1-p546
    • Laboratory Findings of 302 Patients with Hyperinsulinemic Hypoglycemia at Hypoglycemia

      hrp0086p1-p547
    • Recognition of a Sequence: More Growth before Birth, Longer Telomeres at Birth, More Lean Mass after Birth

      hrp0086p1-p548
    • Congenital Hyperinsulinism in Infancy: The Profiles of Insulin Secretory Granules are Markedly Different in Focal- and Diffuse [beta]-Cells

      hrp0086p1-p549
    • Persistent Ketotic Hypoglycemia as an Atypical Presentation of Heterozygous HNF4A Mutation

      hrp0086p1-p550
    • Enhanced Mitochondrial Densities Associate with the Pathobiology of [beta]-Cells in Congenital Hyperinsulinism in Infancy

      hrp0086p1-p551
    • Congenital Adrenal Hyperplasia Newborn Screening: Improving the Effectiveness of the Neonatal 17OH-Progesterone and Serum Confirmatory Tests

      hrp0086p1-p552
    • Neonatal Diabetes in Ukraine

      hrp0086p1-p553
    • Clinical and Molecular Characteristics of Turkish Patients with Congenital Hyperinsulinism: A Single-Center Experience

      hrp0086p1-p554
    • Islet of Langerhans in Congenital Hyperinsulinism in Infancy are Disrupted and with Decreased Expression of Collagen (IV) [alpha]1 Chain in Basement Membranes

      hrp0086p1-p555
    • Pancreatic Glucagon Secretion is Severely Impaired and Somatostatin Secretion Unchanged in Patients with Hyperinsulinaemic Hypoglycaemia

      hrp0086p1-p556
    • Mutations in MODY Genes: About Four Cases of Congenital Hyperinsulinism

      hrp0086p1-p557
    • Cerebral Outcome of Children with Congenital Hyperinsulism

      hrp0086p1-p558
    • Recognition of the Fetal and Perinatal Features of the Prader-Willi Syndrome is Required to Avoid Delay in Diagnosis

      hrp0086p1-p559
    • Congenital Hyperinsulinism Due to Compound Heterozygous Mutation in ABCC8 and KCNJ11 GENES: 20 Years Experience of A National Referral Centre

      hrp0086p1-p560
    • A Case of Hyperinsulinemic Hypoglycemia, Associated with Insulin Autoimmune Syndrome (IAS) in 3.5 Year Old Girl

      hrp0086p1-p561
    • Effectiveness of Calcium Channel Blocker Nifedipine in Children with Hyperinsulinaemic Hypoglycaemia Due to Genetically Proven Mutations in the ABCC8/KCNJ11/GCK Genes

      hrp0086p1-p562
    • Hyponatremia in Infants Under 100 Days Old: Frequently Overlooked and Multifactorial

      hrp0086p1-p563
    • Long-Term Effects of Differences in Fetal Environment: Endocrine Influences on Cognitive Function and Personality in Teen Monozygotic Twins

      hrp0086p1-p564
    • Different Long-term Neurodevelopmental Outcomes in Very Preterm Versus Very-low-birth-weight Infants

      hrp0086p1-p565
    • Challenging Management of Costello Syndrome with Severe Congenital Hyperinsulinaemic Hypoglycaemia

      hrp0086p1-p566
    • Risk Factors and Clinical Features of a Large Cohort of Patients with Transient Hyperinsulinemic Hypoglycaemia

      hrp0086p1-p567
    • A Rare Case of Neonatal Hypothyroidism

      hrp0086p1-p568
    • Maternal Nutritional Risk Factors Associated with Neonatal Hyperinsulinism

      hrp0086p1-p569
  • Perinatal Endocrinology P2
  • • Genotype and Phenotype of 99 Vietnamese Patients with Congenital Hyperinsulinism

      hrp0086p2-p570
    • The Effects of Serum Insulin, Leptin, Ghrelin, Adiponectin and Resistin Levels on Early Postnatal Growth in Small for Gestational Age Newborns

      hrp0086p2-p571
    • Sirolimus Therapy in Infant with Congenital Hyperinsulinemic Hypoglycemia Unresponsive to Diaxoside

      hrp0086p2-p572
    • IPEX Syndrome Caused by A Novel Mutation in Foxp3 Gene: A Case Report

      hrp0086p2-p573
    • Use of a Cord Blood F-Dex Monocyte Binding Assay to Study the Glucocorticoid Sensitivity in Premature Neonates

      hrp0086p2-p574
    • Persistent Hyperinsulinemic Hypoglycemic of Infancy

      hrp0086p2-p575
    • The Postnatal Effect of Serum Vitamin D Binding Protein on Serum Vitamin D Level

      hrp0086p2-p576
    • Endocrinologists Have A Role in Moderating Adverse Metabolic Consequences of Early Over Feeding of Children Born IUGR

      hrp0086p2-p577
    • Primary Hyperparathyroidism in Children and Adolescents: About a Series of Ten Patients

      hrp0086p2-p578
    • The Effects of Serum Leptin, Ghrelin, Adiponectin and Resistin Levels on Early Postnatal Growth in Infants of Diabetic Mothers

      hrp0086p2-p579
    • Newborns of Mothers Affected by Autoinmune Thyroid Disease

      hrp0086p2-p580
    • Missense Mutation of GLIS3 Gene Resulting Inneonatal Diabetes and Congenital Hypothyroidism

      hrp0086p2-p581
    • Birth Chest Circumference Relations to Circulating Insulin-Like Growth Factor-I in the Not-life-threatened Newborn: Relevance of Birthweight to Birth Crown-Heel Length Ratio Beyond The Presence of a Small Birthweight for Gestational Age and of Respiratory Support Measures

      hrp0086p2-p582
    • Neonatal Failure to Thrive and Dyselectrolytemia - Not Always a Congenital Adrenal Hyperplasia

      hrp0086p2-p583
    • A Unique IL2RA Mutation Presenting as Neonatal Diabetes, Congenital Hypothyroidism and Sepsis

      hrp0086p2-p584
    • Change Level of TRAb in Newborn Leads to Thyroid Dysfunction - Case Report

      hrp0086p2-p585
    • Hyperthyrotropinemia of the Preterm Newborn: Treat or Not to Treat?

      hrp0086p2-p586
    • Permanent Neonatal Diabetes Mellitus Due to a G32S Heterozygous Mutation in the Insulin Gene

      hrp0086p2-p587
    • Case Report on Hyperinsulinism/hyperammonaemia Syndrome: An Easily Treatable Cause of Postprandial Hypoglycaemia

      hrp0086p2-p588
    • Severe Systemic Pseudohypoaldosteronism Type 1: 5 Years of Evolution

      hrp0086p2-p589
    • Birth Chest Circumference Relations to Circulating Insulin-Like Growth Factor Binding Protein-3 in The Not-Life-Threatened Newborn: Relevance of Birthweight to Birth Crown-Heel Length Ratio After Control for A Small Birthweight for Gestational Age, for Respiratory Support Measures and for Circulating Insulin-Like Growth Factor-I

      hrp0086p2-p590
    • Renal form of Pseudohypoaldosteronism Type I in Sucking: Clinical Case

      hrp0086p2-p591
    • Neonatal Hyperparathyroidism with Homozygous Missense Mutation in the CASR Gene

      hrp0086p2-p592
  • Growth P1
  • • The Mechanistic Role of Fibroblast Growth Factor 21 (FGF21) in Growth Hormone Resistance Secondary to Chronic Childhood Conditions

      hrp0086p1-p593
    • Somapacitan, a Once-Weekly Reversible Albumin-Binding Growth Hormone (GH) Derivative, Is Well Tolerated and Convenient in Adults with GH Deficiency (AGHD): Results from a 26-Week Randomised, Controlled Phase 3 Trial

      hrp0086p1-p594
    • The Diagnostic Value of IGF-II, IGF-I and IGFBP-3 in Silver-Russell Syndrome

      hrp0086p1-p595
    • Functional in vitro Characterization of Two Novel Germinal STAT3 Mutations Associated with Short Stature, Immunodeficiency and Autoimmune Disease

      hrp0086p1-p596
    • Abstract unavailable

      hrp0086p1-p597
    • Human Phase1 Clinical Data of ALT-P1 (hGH-NexP) by Healthy Korean Males

      hrp0086p1-p598
    • Validation of Prediction Models for Near Final Adult Height in Children with Idiopathic Growth Hormone Deficiency Treated with Growth Hormone for 1 Year

      hrp0086p1-p599
    • The Influence of Recombinant Human Growth Hormone Treatment on Very Small Embryonic/Epiblast Like Stem Cells

      hrp0086p1-p600
    • A Lipid-Based System for the Oral Delivery of Growth Hormone

      hrp0086p1-p601
    • Prediction of First Year Response to Growth Hormone Treatment in Neural Network Models

      hrp0086p1-p602
    • Pediatric Phase 2 Data Demonstrate that TransCon hGH Has an Anti-hGH Immunogenic Profile that is Comparable to Daily hGH

      hrp0086p1-p603
    • The Exon3-Deleted Growth Hormone Receptor Gene Polymorphism (d3-GHR) is Associated with Increased Spontaneous Growth and Impaired Insulin Sensitivity in Prepubertal Short SGA Children (NESGAS)

      hrp0086p1-p604
    • A New Case of Intragenic Deletion in IGF1R with Very Mild Phenotype

      hrp0086p1-p605
    • The Role of IGF-1R Gene Polymorphisms with Regard to Susceptibility to Idiopathic Short Stature Risk in the Chinese Population of Jiangxi Area

      hrp0086p1-p606
    • Effects of the Addition of Metformin to Recombinant Human GH on Bone Maturation and Pubertal Progression in Short Children Born Small-for-Gestational-Age

      hrp0086p1-p607
    • Pubertal Height Gain in Females with Isolated Growth Hormone Deficiency Treated with rhGH Alone or in Combination with GnRHan

      hrp0086p1-p608
    • Cognitive Abilities and Academic Achievement Among Youths with Short Stature Receiving Growth Hormone Therapy

      hrp0086p1-p609
    • One Year Use of Anastrazole Improves the Predicted Adult Height of Male Adolescents with and without Associated GH Therapy

      hrp0086p1-p610
    • IGFALS Gene Deletion in a Family with Short Stature

      hrp0086p1-p611
    • Adherence with Twice-Monthly, At-Home Dosing Schedule of Somavaratan (VRS-317) Long-Acting Growth Hormone Treatment in Children with Growth Hormone Deficiency (GHD) (NCT02068521)

      hrp0086p1-p612
    • Glucose Dysregulation in Children with Growth Hormone Deficiency (GHD), Turner Syndrome (TS) or Born Small for Gestational Age (SGA) Treated with GH: A Report from the NordiNet International Outcome Study (IOS)

      hrp0086p1-p613
    • Serum [alpha]-Klotho Levels are not Informative for the Evaluation of GH Secretion in Short Children

      hrp0086p1-p614
    • Immunogenicity Results of Once-Weekly Administration of CTP-Modified Human Growth Hormone (MOD-4023): A Phase 2 Study in Children with Growth Hormone Deficiency

      hrp0086p1-p615
    • Serum IGF-I, IGFBP-3 and Als Concentrations and Physical Performance in Young Swimers During a Training Season

      hrp0086p1-p616
    • The Blood Antioxidant System in Adult Growth Hormone Deficient Patients after Concluded Childhood Growth Hormone Therapy

      hrp0086p1-p617
    • Design and Clinical Development of TransCon Growth Hormone for Growth Hormone Deficiency (GHD)

      hrp0086p1-p618
    • Mutations in PROP1 Gene in Combination with 47,XYY Karyotype: Case Report

      hrp0086p1-p619
    • Efficacy of Growth Hormone Treatment in Patients with Type 1 Diabetes Mellitus and Growth Hormone Deficiency

      hrp0086p1-p620
    • Final Height after Growth Hormone Treatment in Children with Chronic Renal Failure

      hrp0086p1-p621
    • Major Plasma Carotenoids Levels in Growth Hormone Deficient Children

      hrp0086p1-p622
    • Autosomal Dominant Growth Hormone Deficiency due to a Novel Mutation in the gh1 Gene

      hrp0086p1-p623
    • A Novel GH1 Mutation in a Family with Autosomal-Dominant Type II Isolated Growth Hormone Deficiency

      hrp0086p1-p624
    • 2nd Year Pharmacokinetic and Pharmacodynamic Modeling of Long-Acting Human Growth Hormone (MOD 4023) in Growth Hormone Deficient Children

      hrp0086p1-p625
    • Significance of IGF-I Generation Test in Diagnosing Primary and Non-Primary IGF-I Deficiency - Clinical Considerations

      hrp0086p1-p626
    • Change of Growth Pattern and Thickness of Epiphyseal Plate in Female Rats According to Injected Estrogen Dosage

      hrp0086p1-p627
    • Height Gain and Safety Outcomes in Growth Hormone (GH)-Treated Girls and Boys with Idiopathic Short Stature (ISS): Experience from the Prospective GeNeSIS Observational Study

      hrp0086p1-p628
    • Treatment of Resistant Paediatric Somatotropinomas due to AIP Mutation with Pegvisomant

      hrp0086p1-p629
    • GH-Pattern with High Trophs are Often Found after Daily sc rhGH-Injection in Children

      hrp0086p1-p630
    • Are the GH Treatment Doses in Use within Secretion Rates of Healthy Children?

      hrp0086p1-p631
    • The Influence of Growth Hormone Treatment on Fat-free Mass in Prepubertal Children with Kabuki Syndrome

      hrp0086p1-p632
    • Evaluation of Prepubertal Patients with Suspected Neurosecretory Dysfunction of Growth Hormone Secretion: Diagnostic Steps and Treatment Response

      hrp0086p1-p633
    • Four-Year Results from PATRO Children, a Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment

      hrp0086p1-p634
    • Glucagon vs Clonidine Stimulation for Testing Growth Hormone Secretion in Children and Adolescents: Which is Better?

      hrp0086p1-p635
    • The Use of Tissue Doppler Imaging in Assessing Right and Left Ventricle Diastolic Function in Children with Growth Hormone Deficiency before and after 1-Year Therapy with Growth Hormone

      hrp0086p1-p636
    • Diagnosing GH Deficiency in Children by Arginine Hydrochloride Infusion Test: Relationship between Auxiological Characteristics, Arginine Plasma Profile and Arginine-Stimulated GH Release

      hrp0086p1-p637
    • Retrospective Analysis of Growth Hormone (GH) Treatment Results in Children with Idiopathic Growth Hormone Deficiency (IGHD), Turner Syndrome (TS) and Small for Gestational Age (SGA) using iGRO* in a Pediatric Endocrine Practice

      hrp0086p1-p638
    • Spanish ECOS Study Analysis: Socioeconomic Data, Adherence and Growth Outcomes with Case Studies

      hrp0086p1-p639
    • Analysis of Correlation between Stem Cells (CD133+/CD45+ and CD133+/CD45−) and Anthropometric Parameters of Children with Growth Hormone/Primary Insulin-Like Growth Factor 1 Deficiency

      hrp0086p1-p640
  • Growth P2
  • • Hypochondroplasia (HC) Treatment with rGH: Actualization of Pilot Observations

      hrp0086p2-p641
    • The Influence of Growth Hormone Treatment on the Basal Metabolism in Prepubertal Children with Kabuki Syndrome

      hrp0086p2-p642
    • An Analysis of the Safety of Childhood Growth Hormone (GH) Therapy: Data from the NordiNet® International Outcome Study (IOS)

      hrp0086p2-p643
    • Adverse Effects after Priming with Testosterone in Short Statured Boys before Growth Hormone Stimulation Test

      hrp0086p2-p644
    • Effect of One-Year Growth Hormone Therapy on Serum Levels of Ghrelin and Leptin in Children with Growth Hormone Deficiency and their Correlations with Cardiac Functions and Dimensions

      hrp0086p2-p645
    • Metabolic Parameters and Glucose Homeostasis in Childhood Onset Growth Hormone Deficiency at Time of Initial Evaluation and Retesting

      hrp0086p2-p646
    • Final Adult Height (FAH) in Patients with PROR-1 Gene Mutations during GH Long-Term Therapy

      hrp0086p2-p647
    • Congenital Hypopituitarism: Genotypic-Phenotypic-Neuroradiological Correlation

      hrp0086p2-p648
    • A Case of Hypopituitarism in a Patient with Cantu Syndrome

      hrp0086p2-p649
    • Delaying Puberty with GnRHa does not Promote Adult Height in GH Treated Children Who Enters Puberty at Average Age

      hrp0086p2-p650
    • Estimation of FGF21 Concentration in Prepubertal Children with Growth Hormone Deficiency before and after 6 Months of Growth Hormone Treatment

      hrp0086p2-p651
    • Abstract unavailable

      hrp0086p2-p652
    • Improving the 'Gold Standard': The Insulin Tolerance Test Revisited

      hrp0086p2-p653
    • Adherence to Growth Hormone Therapy: Comparison of Electronic Auto-Injection to Non-Electronic Injection Devices

      hrp0086p2-p654
    • Factors Influencing Peak GH Response During Insulin and Clonidine Stimulation Tests

      hrp0086p2-p655
    • Improved Growth Outcomes with Jet Delivery of Growth Hormone in Children are Maintained Over Long-Term Treatment

      hrp0086p2-p656
    • Septo-Optic Dysplasia and Excellent Growth with Low Growth Hormone Dose: Our Experience

      hrp0086p2-p657
    • Early Diagnosis and Treatment of a Newborn with POU1F1 Mutation

      hrp0086p2-p658
    • Influences of GHR-Exon 3 and -202 A/C IGFBP3 Polymorphisms on 1 Year Follow-Up Outcome of Growth Hormone Treatment in Korean Children with Growth Hormone Deficiency

      hrp0086p2-p659
    • Comparison between Effects of Oral Iron and Vitamin A with Oxandrolone upon Height and Puberty of Children with Constitutional Delay of Growth and Puberty

      hrp0086p2-p660
    • 'First Do No Harm': Growth Hormone (hGH) Treatment in a Case of Recurrent Craniopharyngioma

      hrp0086p2-p661
    • High Efficacy Growth Hormone Therapy in Patient with Homozygous Mutation in Growth Hormone Gene (GH-1) During 3 Years

      hrp0086p2-p662
    • A Case of GH Deficiency in a Female with 3M Syndrome

      hrp0086p2-p663
    • Case Report of SHOX Gene Haploinsufficiency Diagnosed in Early Infancy

      hrp0086p2-p664
    • Association between IGF-1 (Insulin-Like Growth Factor) SD Levels and Children with Growth Hormone Deficiency with and without Pituitary Morphological Abnormalities

      hrp0086p2-p665
    • Usefulness of Growth Hormone Transient Treatment Suspension in Prepubertal Children Treated with Growth Hormone

      hrp0086p2-p666
    • Birth Length, Weight and Head Circumference of Neonates with IGF-I Receptor Mutations

      hrp0086p2-p667
    • A Rare Cause of Growth Delay: Jacobsen Syndrome

      hrp0086p2-p668
    • A GH-1 Mutation Diagnosed in a Preadolescent Obese Girl with Only Mild Reduced Height

      hrp0086p2-p669
    • A New Reusable Manual Pen Device for Injection of Human Growth Hormone: Results of a Convenience and Functionality Evaluation Study

      hrp0086p2-p670
    • Assessing Disease and Treatment Burden for Young Children with Growth Hormone Deficiency (GHD)

      hrp0086p2-p671
    • Long-Term Results of GH Therapy in GH-Deficient Children Treated in Albania

      hrp0086p2-p672
    • Abstract unavailable

      hrp0086p2-p673
    • Did Growth Hormone Treatment Associated with Psychological Status in Children with Short Stature?

      hrp0086p2-p674
    • The Effects and Safety of Recombinant Human GH (rhGH) Treatment on Growth Hormone Deficiency in Children with Rathke's Cleft Cyst

      hrp0086p2-p675
    • Is the Growth Hormone Deficiency the Cause of Short Stature in Floating Harbor Syndrome?

      hrp0086p2-p676
    • LHX-4 Gene Mutation in a Boy with Hypopituitarism and Severe Congenital Myopathy

      hrp0086p2-p677
    • Prevalence and Causes of Short Stature and Impact of GH Therapy among Preschool Children at King Abdul-Aziz Medical City for National Guard in Riyadh, Saudi Arabia

      hrp0086p2-p678
    • Association between Growth Hormone Peak at a Stimulation Test and Pituitary Morphological Findings in Children with Growth Hormone Deficiency

      hrp0086p2-p679
    • A Case of Growth Hormone Deficiency with Combined Encephalocraniocutaneous Lipomatosis and Jaffe-Campanacci Syndrome

      hrp0086p2-p680
    • Evaluation of GH Deficient Pre Pubertal Children Treated with Omnitrope® Using the AuxoLog Computer Program

      hrp0086p2-p681
    • Calcaneal Apophysitis (Sever's Disease) Development in a Case Using Growth Hormone

      hrp0086p2-p682
    • Bone Health Index: A Potential Discriminator between Growth Hormone Deficiency and Constitutional Delay in Growth and Puberty in Adolescent Children

      hrp0086p2-p683
    • Growth Effects of Somatropin during the Treatment Congenital Hypopituitarism in Children after the Start of Puberty

      hrp0086p2-p684
    • Congenital Hypopituitarism and Giant Cell Hepatitis in a Two-Months-Old Boy

      hrp0086p2-p685
    • Neonatal Characteristics of GH Deficiency in 107 Children

      hrp0086p2-p686
    • Diagnostic Value of Growth Hormone Stimulation Test for Growth Hormone Deficiency in Short Children

      hrp0086p2-p687
  • Endocrinology and Multisystemic Diseases P1
  • • Thyrotoxicosis, Nephrogenic Syndrome of Inappropriate Antidiuresis, Tall Stature and Mental Retardation Caused by a Novel GNAS Gain of Function Mutation

      hrp0086p1-p688
    • Novel Germline Mutations in DICER1 Gene in Patients with Different Pediatric Hereditary Tumors

      hrp0086p1-p689
    • Fludrocortisone: A Treatment for Tubulopathy Post Paediatric Renal Transplantation - A Scottish Study

      hrp0086p1-p690
    • Neonatal Diabetes and Congenital Hypothyroidism, a Rare Condition: Report of 2 Cases with Different Genetic Causes

      hrp0086p1-p691
    • Access to Medicines in Pediatric Endocrinology and Diabetes in Africa: Insights from the WHO and National Lists of Essential Medicines

      hrp0086p1-p692
    • Is it Cautious to Wait for Serum Basal Calcitonin Levels Rise in Patients with Ret Codon C634 Mutation?

      hrp0086p1-p693
    • Abstract unavailable

      hrp0086p1-p694
    • CANDLE Syndrome: A New Autoinflammatory Lipodystrophic Disorder with Challenging Diagnosis and Limited Therapeutic Options

      hrp0086p1-p695
    • Variable Phenotype and Genetic Findings in a Cohort of Patients with Pseudohypoparathyroidism

      hrp0086p1-p696
    • Contiguous Gene Syndrome Involving DAX1 Deletion with Congenital Adrenal Insufficiency

      hrp0086p1-p697
    • Clusters of Autoinmune Diseases in Children

      hrp0086p1-p698
    • Role of PTPN22 C1858T Gene Polymorphism in Pediatric Polyautoimmunity

      hrp0086p1-p699
  • Endocrinology and Multisystemic Diseases P2
  • • Effects of 2 Years of Growth Hormone Treatment on Glucose Tolerance in Young Adults with Prader-Willi Syndrome

      hrp0086p2-p700
    • TPIT Mutation may be Involved in Multiple Pituitary Deficiencies

      hrp0086p2-p701
    • Clinical Analysis of 24 Cases of Rathke's Cleft Cysts in Children

      hrp0086p2-p702
    • French National Healthcare Network for Rare Endocrine Diseases (FIRENDO): The First Year of Activity to Monitor Patients with Rare Endocrine Diseases

      hrp0086p2-p703
    • Autoimmune Diseases and Metabolic Outcome in Turner Syndrome - Comparison between 45,X0 and other X Chromosome Abnormalities

      hrp0086p2-p704
    • Endocrinological Disorders in Children with Neurofibromatosis Type 1 and Optic Pathway Gliomas

      hrp0086p2-p705
    • Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Managed with Fluid Restriction and Salt Supplementation

      hrp0086p2-p706
    • The Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Non-High-Density Lipoprotein Cholesterol Reference Data for Korean Children and Adolescents: Results of the 2007-2013 Korean National Health and Nutrition Examination Surveys (KHANES)

      hrp0086p2-p707
    • Inhibition of NAMPT Increases the Sensitivity of Leukemia Cells for Etoposide

      hrp0086p2-p708
    • Neonatal Endocrinological Problems in Collodion Babies

      hrp0086p2-p709
    • Endocrine Dysfunction in Children and Adolescents with CHARGE Syndrome

      hrp0086p2-p710
    • Growth and Pubertal Patterns in Young Survivors of Childhood Acute Lymphoblastic Leukemia

      hrp0086p2-p711
    • Clinical Assessment of Hypercalciuria and Hypomagnesemia in Patients with Bartter Syndrome and Gitelman Syndrome

      hrp0086p2-p712
    • Wolfram Syndrome: Three Cases

      hrp0086p2-p713
    • Autoimmune Hypoparathyroidism and Celiac Disease: A Rare Paediatric Association Outside an Autoimmune Polyglandular Syndrome

      hrp0086p2-p714
    • Management of Endocrine Complications of Thalassemia

      hrp0086p2-p715
    • Endocrine Disorders in Children with Thalassemia Major - A Hospital Based Retrospective Study

      hrp0086p2-p716
    • 15-Year Old Girl with APS Type IIIc, with Post-Thymectomy Remission - Case Report

      hrp0086p2-p717
    • Endocrine and Metabolic Evaluation of Children with Neurodevelopmental Disability

      hrp0086p2-p718
    • Endocrine Complication in Survivors of Childhood Cancers

      hrp0086p2-p719
    • Familial Williams Syndrome

      hrp0086p2-p720
    • Stanazolol Abuse: Diagnostic Dilemma in an Adolescent with Persistent Hypoglycemia

      hrp0086p2-p721
  • Pituitary and Neuroendocrinology P1
  • • Role of the Metabotropic mGlu5 Glutamate Receptor in the Initiation of Puberty and Reproduction in Female Mice

      hrp0086p1-p722
    • Effect of Dietary Control on Pubertal Onset and Immunoreactivity of Kisspeptin and Neurokinin B in Female Offspring Rats Fed High Fat Diet During Perinatal Period

      hrp0086p1-p723
    • Estimating the Psychosocial Impact of Idiopathic Central Precocious Puberty (ICPP) in Girls Aged 6 to 8 Years: A Qualitative Study

      hrp0086p1-p724
    • Metabolic and Pubertal Alterations in Children with Narcolepsy-Cataplexy

      hrp0086p1-p725
    • Time Course of Central Precocious Puberty Development Caused by an MKRN3 Gene Mutation: A Prismatic Case

      hrp0086p1-p726
    • Changes of Serum AMH and Inhibin B Levels in Girls with Central Precocious Puberty before and During Treatment with GnRH Agonists

      hrp0086p1-p727
    • FGFR1 Loss-of-Function Mutations of in Three Japanese Patients with Isolated Hypogonadotropic Hypogonadism and Split Hand/Foot Malformation

      hrp0086p1-p728
    • Clinical and Mutational Spectrum in Slovenian Patients with Hypogonadotropic Hypogonadism

      hrp0086p1-p729
    • MKRN3 Mutations and Central Precocious Puberty

      hrp0086p1-p730
    • Precocious Puberty in Patients with Primary Adrenal Insufficiency due to Melanocortın Receptor 2 Mutation

      hrp0086p1-p731
    • Association between Estrogen Receptor Gene Polymorphisms and Premature Thelarche

      hrp0086p1-p732
    • The Influences of Circulating Leptin, Kisspeptin, and Neurokinin B Levels to Precocious Puberty in Obese Girls

      hrp0086p1-p733
    • Pseudopuberty in a Young Girl with Adrenocortical Carcinoma During Mitotane Therapy

      hrp0086p1-p734
    • Prolactinomas in Children and Young Adults: 10 Year Experience in a Tertiary Regional Paediatric - Young Adult - NeuroEndocrine Surgical Centre

      hrp0086p1-p735
    • Cut-Off Values for Nocturnal Salivary Testosterone to Enable Detection of Early Puberty

      hrp0086p1-p736
    • Screening of PROP-1, LHX2 and POU1F1 Mutations in Patients with Ectopic Posterior Pituitary Gland

      hrp0086p1-p737
    • Oxytocin Deficiency is Associated with Hyperphagia and Weight Gain in Hypothalamic and Common Obesity: A First-in-Humans Proof-of-Concept Study

      hrp0086p1-p738
    • Evaluation of Puberty in Children with Sickle Cell Anemia: A Case Control Study in Yaounde, Cameroon

      hrp0086p1-p739
    • Standard Triptorelin Therapy May Not Fully Suppress Pubertal Progress in Adolescents with Gender Dysphoria

      hrp0086p1-p740
    • Serum Anti-Mullerian Hormone Levels in Precocious Puberty Girls According to the Timing of GnRH Agonist Treatment

      hrp0086p1-p741
    • Precocious Puberty in Septo-Optic Dysplasia Syndrome - Presentation of 2 Cases

      hrp0086p1-p742
    • Proton Therapy as a Promising Therapeutic Option for Children with Aggressive and Uncontrolled Pituitary Macro Adenoma: A Case Report

      hrp0086p1-p743
    • A Prospective Evaluation of Urinary Gonadotrophins for Assessment and Management of Pubertal Disorders

      hrp0086p1-p744
    • Constitutional Delay of Puberty or Hypogonadotropic Hypogonadism: Diagnostic Value of Inhibin B and AMH Measurements

      hrp0086p1-p745
    • Prognostic Significance of the Proliferative Index Ki67 for Patients with Craniopharyngiomas

      hrp0086p1-p746
    • Etiology, Differential Diagnosis and Clinical Course of Delayed Puberty: A Single Center Experience

      hrp0086p1-p747
    • GH Therapy Assessment in GH Deficient Patients During the Transition Period

      hrp0086p1-p748
    • Age of Onset of Puberty in Yaounde, Which Normative Reference Data?

      hrp0086p1-p749
    • Personalized Health Care: Home POCT Sodium Measurement in Diabetes Insipidus Centralis in a Patient with Impaired Thirst Perception

      hrp0086p1-p750
    • Transcriptional Basis of Idiopathic Central Hypogonadism in Isolated Congenital Cryptorchidism with Defective Mini-Puberty

      hrp0086p1-p751
    • A Novel MKRN3 Frameshift Mutation in a Bulgarian Girl with Central Precocious Puberty

      hrp0086p1-p752
    • The Intra- and Inter-User Reliability of Testicular Volume Estimation - A Simulation Study

      hrp0086p1-p753
    • The Metabolic Negative Effect of Gonadotropin-Releasing Hormone Agonist Therapy in Childhood: Is it Short-Term and Reversible?

      hrp0086p1-p754
    • Gonadotropin-Releasing Hormone Stimulation Test in Girls Younger than 3 Years Old: Does the Stimulated LH Greater Than 5 IU/l Always Mark Central Puberty Precoccious?

      hrp0086p1-p755
    • [beta]-hCG from an Occult Source Causing Peripheral Precocious Puberty: Identification of the Tumour 6 Years After Presentation

      hrp0086p1-p756
    • Silent Corticotroph Adenoma with Adrenocortical Choristoma in an 11-Years Old Boy

      hrp0086p1-p757
  • Pituitary and Neuroendocrinology P2
  • • Clinical Symptoms, Endocrine Dysfunction and Radiologic Findings in Children with Rathke's Cleft Cyst

      hrp0086p2-p758
    • A Case of Central Precocious Puberty in a Patient with Prader-Willi Syndrome

      hrp0086p2-p759
    • Is Amh Level Diagnostic for Premature Telarche, Premature Adrenarche and Central Precocious Puberty?

      hrp0086p2-p760
    • Paediatric Cushing Disease: One Patient's Path to Cure

      hrp0086p2-p761
    • Recovery of Hypothalamic Pituitary Function After Stalk Transection and Panhypopituitarism in an Adolescent

      hrp0086p2-p762
    • A Novel CHD7 Mutation in an Adolescent Presenting with Pubertal and Growth Delay

      hrp0086p2-p763
    • Kallmann Syndrome Due to a Homozygous Missense c.217C>T (p.R73C) Mutation Detected in the Exon-2 of the PROK2 Gene

      hrp0086p2-p764
    • Symptomatic Rathke Cleft Cyst in Pediatric Patients - Clinical Presentations, Surgical Treatment and Postoperative Outcomes - An Analysis of 38 Cases

      hrp0086p2-p765
    • Congenital Craniopharyngioma: Report of Two Cases

      hrp0086p2-p766
    • Congenital Hypopituitarism in a Patient with 18p- Syndrome

      hrp0086p2-p767
    • 10 Years Review of Endocrine Diseases in Spanish Patients Diagnosed with Primary Brain Tumors in a Tertiary Hospital

      hrp0086p2-p768
    • Novel Uses of Psychiatric Drugs to Treat Hypothalamic Obesity

      hrp0086p2-p769
    • Postoperative Water and Electrolyte Disorders and Affecting Factors in Children with Intracranial Tumors

      hrp0086p2-p770
    • Compound Heterozygosity for Two Novel POU1F1 Mutations in Siblings with Isolated Childhood Onset Growth Hormone Deficiency (CO-GHD)

      hrp0086p2-p771
    • Brain MRI in Evaluation of Endocrine Diseases of Childhood: Causal and Incidental Lesions

      hrp0086p2-p772
    • Primary Thirst Defect is a Rare But Important Complication Following Surgery for Hypothalamic Hamartoma and Intractable Epilepsy

      hrp0086p2-p773
    • Insulin Sensitivity in Girls with Central Precocious Puberty at Diagnosis and at 6 Months of GnRH Analogue Treatment

      hrp0086p2-p774
    • Effect of Gonadotropin Releasing Hormone Analogues (GnRHa) on Final Height in Girls with Borderline Early Puberty or Normal Physiological Puberty Depend on Bone Age Advancement and Predicted Height

      hrp0086p2-p775
    • Central Nervous System Abnormalities on Brain Magnetic Resonance Imaging Among 200 Korean Girls with Central Precocious Puberty

      hrp0086p2-p776
    • Impaired Growth Hormone Secretion Associated with Large Hypothalamic Hamartoma

      hrp0086p2-p777
    • Comparison of Triptorelin Versus Leuprolide in Treatment of Girls with Central Precocious Puberty

      hrp0086p2-p778
    • Central Precocious Puberty in a Female with Gonadal Dysgenesis and Bilateral Gonadoblastoma

      hrp0086p2-p779
    • Precocious Puberty: A Single Academic Center Experience

      hrp0086p2-p780
    • Does Pituitary Volume have the Diagnostic Value on Growth Hormone Deficiency and Prognostic value on the Response to Growth Hormone Therapy?

      hrp0086p2-p781
    • Early Puberty; Diagnosis, Treatment and Prognosis

      hrp0086p2-p782
    • Basal Levels of FSH and LH can be Helpfull in Diagnosis of Puberty Precocious?

      hrp0086p2-p783
    • Body Mass Index and Body Fat Composition are Both Related to Central Precocious Puberty in Chinese Girls

      hrp0086p2-p784
    • Hyperleptinemia in Obese and Non-Obese Children with Early Puberty

      hrp0086p2-p785
    • Association between Congenital Hypopituitarism and Agenesis of the Internal Carotid Artery: A Case Report

      hrp0086p2-p786
    • Giant Macroprolactinoma in a Female Adolescent - Case Report

      hrp0086p2-p787
    • Adenomas Pituitary in Children

      hrp0086p2-p788
    • A Patient with Multiple Endocrine Neoplasia Type 1 Presented with Precocious Puberty

      hrp0086p2-p789
    • Precocious Puberty in a Girl With Prader Willi Syndrome

      hrp0086p2-p790
    • Menstrualcharacteristics and Problems in 9-18 Years Old Turkish School Girls

      hrp0086p2-p791
    • Haplo-insufficiency for LHX4 Alone does not Result in Hypopituitarism

      hrp0086p2-p792
    • A Nursing Perspective: Best Practices for Pubertal Suppression for Individuals with Central Precocious Puberty and Transgender

      hrp0086p2-p793
    • An Unusual Association between Empty Sella and Central Precocious Puberty

      hrp0086p2-p794
    • Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) in Children Born Small for Gestational Age (SGA) - Our Experiences

      hrp0086p2-p795
    • Severe Juvenile Hypertrophy of the Breast with Hypercalcaemia; Mastectomy v's Reduction Surgery

      hrp0086p2-p796
    • Report Two Cases of Dopa-Responsive Dystonia

      hrp0086p2-p797
  • Syndromes: Mechanisms and Management P1
  • • Abstract unavailable

      hrp0086p1-p798
    • NPR2 Gene Mutations Associated with Acromesomelic Dysplasia Maroteaux Type are Mostly Unique to Families

      hrp0086p1-p799
    • Rare Cases of Ornithine Transcarbamylase Deficiency and Variant Turner Syndrome

      hrp0086p1-p800
    • Prepubertal Ultra-low-dose Estrogen Therapy is Associated with Better Lipid Profile than Conventional Estrogen Replacement for Pubertal Induction in Adolescent Girls with Turner Syndrome - Preliminary results

      hrp0086p1-p801
    • Cognitive Evaluation in Silver Russell Children

      hrp0086p1-p802
    • Body Surface Area Estimation in Girls with Turner Syndrome: Implications for Interpretation of Aortic Sized Index

      hrp0086p1-p803
    • Near-Adult Height in a Large Cohort of Patients with Turner Syndrome and Noonan Syndrome Treated with rhGH: Results from Pfizer International Growth Database

      hrp0086p1-p804
    • Percutaneous Epiphysiodesis Around the Knee Effectively Reduced Predicted Excessive Final Height. Preliminary Results on Final Height, Complications and Satisfaction in a Large Cohort of Dutch Boys and Girls

      hrp0086p1-p805
    • Metabolic Health and Safety of GH-Treatment in Silver-Russell Syndrome

      hrp0086p1-p806
    • Auxological Features in Patients with Juvenile Idiopathic Arthritis Treated with Biologic Therapy Preliminary Study Data

      hrp0086p1-p807
    • Identification of 11p14.1-p15.3 Deletion Probably Associated with Short Stature, Macrocephaly and Delayed Closure of the Fontanelles

      hrp0086p1-p808
    • Early Treatment with rhGH in Patients with Prader-Willi Syndrome Results in Improved Height with No Respiratory Adverse Effects

      hrp0086p1-p809
    • Phenotypic Variability in a Family with a New SHOX Gene Mutation

      hrp0086p1-p810
    • Correlations between Prepubertal and Pubertal Estrogen Levels and Final Height Out-Come in Growth Hormone (GH) Treated Boys with Silver Russell syndrome

      hrp0086p1-p811
    • Skeletal Disproportion in Girls with Turner Syndrome

      hrp0086p1-p812
    • Reconsideration of Mid-Parental Height Calculation

      hrp0086p1-p813
    • Changes to Thyroid Function (TF) Following Treatment with Growth Hormone (GH) Therapy in Children with Prader-Willi Syndrome (PWS)

      hrp0086p1-p814
    • 6-Year-Old Girl with Mutation in DNMT3A - A New Overgrowth Syndrome

      hrp0086p1-p815
    • A Case of Patient with Rubinstein-Taybi Syndrome Type 2 with Complete Deletion of EP300 Gene and Complex Phenotype

      hrp0086p1-p816
    • Silver-Russell Syndrome with 11p15 Epimutation: Clinical Analysis of Adrenarche, Central Puberty and Body Mass Index in a Cohort of French Children

      hrp0086p1-p817
    • Haploinsufficiency of Short Stature Homeobox Containing Gene: Clinical Signs and Anthropometric Measurements in Children

      hrp0086p1-p818
    • Clinical and Molecular Characterization of a Newly Recognized Overgrowth Syndrome: Interstitial 7q22.1-7q22.3 Microdeletion

      hrp0086p1-p819
    • International Cooperative Growth Study, NutropinAq® European Registry (iNCGS): Countries Specificities

      hrp0086p1-p820
    • Case Report of 48,xxyy Syndrome Associated to Father's Radioactive Contamination During the Cesium Accident in Goiania - Goias, Brazil

      hrp0086p1-p821
    • Neonatal Haematological Complication in Noonan Syndrome - Future Concerns about Growth Hormone Therapy

      hrp0086p1-p822
    • Effects of a Stressful Environment (SE) on Height, BMI and Menarche

      hrp0086p1-p823
    • Growth Hormone Deficiency in Noonan Syndrome: Does it Influence Clinical Response to GH Therapy?

      hrp0086p1-p824
    • Screening of Birth Length and Parental Height Detects Infants with Poor Catch-Up Growth at Age 2 Years

      hrp0086p1-p825
    • Etiologic Distribution and Characteristics of Patients with Short Stature in a Pediatric Endocrinology Clinic

      hrp0086p1-p826
    • OSBPL5 Methylation Abnormalities may be Pathogenic in Silver Russell Syndrome Through Genomic Methylation Analysis

      hrp0086p1-p827
    • A Study of Bone Health Index (BHI) in Girls with Turners Syndrome

      hrp0086p1-p828
    • Premature Adrenarche in Silver-Russell Syndrome: A Longitudinal Study

      hrp0086p1-p829
    • A Rare Case of Deletion in 2q24.1: Clinical Features and Response to Gh Hormone Treatment

      hrp0086p1-p830
    • Serum Levels of IL-6, TNF-a, Omentin-1 are Increased in Girls with Turner Syndrome

      hrp0086p1-p831
    • Effect of Dietetic Management on Weight in Children with Bardet-Biedl Syndrome

      hrp0086p1-p832
    • Analysis of Phenotype and HRAS Gene Mutation in a Chinses Girl with Costello Syndrome

      hrp0086p1-p833
  • Syndromes: Mechanisms and Management P2
  • • Auxological Features in Patients with Vernal Keratoconjunctivitis

      hrp0086p2-p834
    • Turner Syndrome: Does GH Treatment Influence Glucose Homeostasis?

      hrp0086p2-p835
    • Renal Anomalies in Children with Turner Syndrome: Experience from a Single-Centre

      hrp0086p2-p836
    • Abstract unavailable

      hrp0086p2-p837
    • A Novel Fibrillin-1 Gene Mutation Leading to Marfan Syndrome in Korean Girl

      hrp0086p2-p838
    • Evaluation of Referrals for Short Stature to a Regional Paediatric Centre

      hrp0086p2-p839
    • Testosterone Therapy Improves the First Year Height Velocity in Adolescent Boys with Constitutional Delay of Growth and Puberty

      hrp0086p2-p840
    • Safety and Efficacy of Growth Hormone (GH) in Combination with the Gonadotrophin Releasing Hormone Agonist Leuprorelin in Pubertal Children with Idiopathic Short Stature

      hrp0086p2-p841
    • Linear Growth in Infants and Children with Atopic Dermatitis

      hrp0086p2-p842
    • The Specific Pubertal Height Gain is Higher in Boys as Well as in Children with Lower BMI_SDS

      hrp0086p2-p843
    • Growth Screening in Children Aged Three to Five Years Seen in Community Paediatrics in Dreux District, France: Preliminary Results

      hrp0086p2-p844
    • The 3M Syndrome: A Cause of Pre- and Post-Natal Severe Growth Retardation

      hrp0086p2-p845
    • Should We Construct Specific Growth Charts for Ethnic Subgroups?

      hrp0086p2-p846
    • Late Presenting Girls with Turner Syndrome can Achieve a Normal Final Height

      hrp0086p2-p847
    • Growth of Children Born Preterm During the First 8 Years of Life

      hrp0086p2-p848
    • Genetic Variability in Patients with Noonan Syndrome in the Republic of Macedonia

      hrp0086p2-p849
    • An Unusual Cause of Short Stature in a Phenotypic Male with Type I Diabetes Mellitus due to an Unexpected Deletion of the Y Chromosome

      hrp0086p2-p850
    • An Unusual Case of Growth Hormone Replacement Therapy in a Child with Hereditary Multiple Exostoses and Growth Hormone Deficiency

      hrp0086p2-p851
    • Assessment of the Medical and Psychological Status of Women with Turner-Syndrome in Young Adulthood

      hrp0086p2-p852
    • A 3-year-old Boy with Growth Hormone Deficiency and Clinical Features of Ritscher-Schinzel Syndrome

      hrp0086p2-p853
    • Growth Pattern, Response to GH Treatment and the Effects of Pubertal Spurt on Final Height in Patients Affected by RASopathies

      hrp0086p2-p854
    • The Usefulness of Magnetic Resonance Imaging of the Heart and Aorta in the Diagnostic Work-up in Girls with Turner Syndrome

      hrp0086p2-p855
    • A Rare Cause of Short Stature: Patient with 3M Syndrome Revealed a New Mutation in Osbl1 Gene

      hrp0086p2-p856
    • A Case of Familial Silver-Russell Syndrome

      hrp0086p2-p857
    • Central Precocious Puberty in a Case of SOTOS Syndrome

      hrp0086p2-p858
    • Hypoglycaemia in Isolated GH Deficiency beyond Infancy

      hrp0086p2-p859
    • Referral Pattern of Children with Short Stature to a Pediatric Endocrine Clinic in Kuwait

      hrp0086p2-p860
    • The Effect of Iron Intervention on the Anthropometric Parameters: Pilot Study among Egyptian Preschool Children with Iron Deficiency Anemia

      hrp0086p2-p861
    • Dopamine Beta-Hydroxylase Deficiency Leading to Growth Hormone Deficiency

      hrp0086p2-p862
    • Quality of Life in Growth Hormone Treated Children and Adolescents with Growth Hormone Deficiency and Smallness for Gestational Age

      hrp0086p2-p863
    • Secretion of Somatostatin and Growth Hormone (GH) in Various Forms of Hereditary Pathology

      hrp0086p2-p864
    • Postnatal Growth and Factors Modifying it in Very Low Birth Weight Preterms (PT) with Bronchopulmonary Dysplasia (BPD)

      hrp0086p2-p865
    • Endocrine and Metabolic Parameters before Onset of rGH Treatment: Potential Predictive Factors of GH Response in Children Born SGA? Results from Cohort of Nancy

      hrp0086p2-p866
    • Growth Hormone Treatment in a Child with Trisomy 21 and Turner Mosaicism

      hrp0086p2-p867
    • Pubertal Development and Final Height in Some Rare Genetic Diseases

      hrp0086p2-p868
    • Growth Hormone Deficiency in a Patient with Ring Chromosome 18

      hrp0086p2-p869
    • Children with Down's Syndrome Show Quantitative, Phenotypical and Functional Differences of Effector T-Cells Compared to Immunocompetent Controls

      hrp0086p2-p870
    • Cardiovascular Anomalies in Turner Syndrome

      hrp0086p2-p871
    • Metamemory in Turner Syndrome: A Study Comparing Episodic and Semantic Memory

      hrp0086p2-p872
    • A XO/XX Girl with Lack of Morphological UTS-Features, Short Stature and Precocious Puberty

      hrp0086p2-p873
    • Transverse Myelitis in Turner Syndrome

      hrp0086p2-p874
    • Tricho-Rhino-Phalangeal Syndrome Type I in a Girl with Growth Hormone Deficiency

      hrp0086p2-p875
    • Project Epi Peg-Premeb. Clinical Situation of a Person Born SGA Followed from Birth Cohort. GLOBAL Causes and Clinical Situation of Partial Birth Cohort and 12 Months

      hrp0086p2-p876
    • Pituitary Gigantism and Central Precocious Puberty Presenting with Prognathism in a Pediatric Patient

      hrp0086p2-p877
    • The Monitoring of Endocrine Functions in Children with Rare Genetic Syndromes

      hrp0086p2-p878
    • SHORT Syndrome and rhGH Treatment - Is It Useful?

      hrp0086p2-p879
    • Late Diagnosis of Mixed Gonadal Dysgenesis - Clinical and Psychological Implications

      hrp0086p2-p880
    • The Structure of Genetically Determined Types of Short Stature in Uzbekistan According to Retrospective Analysis

      hrp0086p2-p881
    • Evaluation of Growth Pattern in Prader-Willi Syndrome

      hrp0086p2-p882
    • Prader-Willi Syndrome - Different Patients, Different Attitude

      hrp0086p2-p883
  • Thyroid P1
  • • Clinicopathological Characteristics of Papillary Thyroid Cancer in Children With Emphasis on the Pubertal Status and Association With BRAFV600E Mutation

      hrp0086p1-p884
    • Elevation of Serum Fibroblast Growth Factor 21 in Congenital Hypothyroidism

      hrp0086p1-p885
    • Evaluation of Epicardial AdiposeTissue Thickness in Children Detected Subclinical Hypothyroidism

      hrp0086p1-p886
    • EEG Alterations are Common in Hashimoto's Thyroiditis

      hrp0086p1-p887
    • [ldquo]Semi-Hot[rdquo] Thyroid Nodules Associated with GNAS Mutations in Three Adolescents

      hrp0086p1-p888
    • Evaluation of Body Composition via Bioelectrical Impedance Analysis in Children with Subclinical Hypothyroidism and Effect of LT4 Treatment; Follow-up Results

      hrp0086p1-p889
    • The Molecular Causes of Congenital Hypothyroidism: The Scottish experience

      hrp0086p1-p890
    • Newborn Screening Program for Congenital Hypothyroidism: Eighteen Years of Experience in Buenos Aires Province, Argentina

      hrp0086p1-p891
    • Transient TSH Elevation in Infants Referred on Newborn Screening - Features, Prevalence and Trends

      hrp0086p1-p892
    • Resolution of Hepatic Hemangiomas and Consumptive Hypothyroidism in an Infant Treated with Propranolol and Levothyroxine

      hrp0086p1-p893
    • Comprehensive Analysis of Seven Toll-Like Receptor Genes Including 15 Single-Nucleotide Polymorphisms with Autoimmune Thyroid Disease in Korean Children

      hrp0086p1-p894
    • Thyroid Cancer is the Most Frequent Secondary Solid Tumour Following Allogeneic Stem Cell Transplantation in Childhood - A Single Centre Experience

      hrp0086p1-p895
    • Iodide Transport Defect: Identification of a Novel Mutation in the Carboxy-terminus of the Sodium/iodide Symporter in a Pediatric Patient with Congenital Hypothyroidism

      hrp0086p1-p896
    • Congenital Hypothyroidism: The Use of a TSH Cut-off Limit of 6mU/L and the ESPE Criteria for LT4 Treatment Leads to the Diagnosis of Mild but mostly Permanent Forms of Hypothyroidism

      hrp0086p1-p897
    • Do Different Initial Doses of L-T4 within the Range of 10-15 mcg/kg/day Influence Neurodevelopment during the First Two Years of Life in Children with Congenital Hypothyroidism?

      hrp0086p1-p898
    • Clinical and Histopathologic Features and Follow-up of Paediatric Patients with Papillary Thyroid Cancer: A 10 Years Experience

      hrp0086p1-p899
    • Meta-analysis of Children with Multiple Endocrine Neoplasia (MEN) Type 2A from 1995-2014: Impact of RET Mutation Screening on Age at Thyroidectomy and Frequency of Metastatic Disease

      hrp0086p1-p900
    • Screening of Congenital Hypothyroidism in Low Birth Weight and Very Low Birth Weight Neonates: A Systematic Review

      hrp0086p1-p901
    • Identification of Zinc Transporter ZnT8 in Thyroid Tissues from Children and Adolescents with Thyroid Nodular Hyperplasia

      hrp0086p1-p902
    • HABP2 as Genetic Susceptibility Factor for Familial Differentiated Thyroid Carcinoma

      hrp0086p1-p903
    • Cardiac Size and Function in Children with Subclinical Hypothyroidism

      hrp0086p1-p904
    • Association of CTLA4, PADI4 and FTO Polymorphisms with Autoimmune Thyroid Diseases in Male Children

      hrp0086p1-p905
    • Thyroid Cancers in Korean Pediatric Populations with Thyroid Nodules

      hrp0086p1-p906
    • Dysregulation of the Immune System in Children with Graves Disease - the Role of NK and NKT-Like Cells

      hrp0086p1-p907
    • Thyroid Function Anomalies in Children with Down Syndrome: Early TSH Alteration can Predict Future Hypothyroidism Development?

      hrp0086p1-p908
    • Identification of a [ldquo]Cryptic[rdquo] De Novo Deletion in NKX2.1 in the Brain-Lung-Thyroid Syndrome using Genomic SNP Arrays

      hrp0086p1-p909
    • Partial Thyroxine Binding Globulin Deficiency in Test Tube Babies: Cases Report and Literatures Review

      hrp0086p1-p910
    • Hyperthyroidism after Bone Marrow Transplantation: A Report of Two Cases

      hrp0086p1-p911
    • A Case of a Young Girl with High Risk RET Mutation Successfully Diagnosed as Medullary Thyroid Carcinoma in Very Early Stage

      hrp0086p1-p912
    • Nerve Conduction Studies in Children with Subclinical Hypothyroidism

      hrp0086p1-p913
    • Van Wyk Grumbach Syndrome with Kocher Smeglaine Debre Syndrome: Case Report of a Rare Association

      hrp0086p1-p914
    • Macro TSH- a Rare Cause of High Levels of TSH

      hrp0086p1-p915
    • Papillary Thyroid Carcinoma in a Mother and Child Evolving after the Manifestation of Grave's Disease

      hrp0086p1-p916
    • Hypercholesterolemia in Two Siblings with THRB Mutation

      hrp0086p1-p917
    • Thyroid Autoimmunity and Vitamin D Status in Euthyroid Girls with Hashimoto's Thyroiditis

      hrp0086p1-p918
    • Etiology and Severity of Congenital Hypothyroid Children Detected through Neonatal Screening: A Cut-off based Analysis

      hrp0086p1-p919
    • Lowering of the TSH cut-off Limit Substantially Alters Universally Accepted Key Features of Congenital Hypothyroidism. Reconsideration of the Use of FT4 levels for Diagnosis and Treatment

      hrp0086p1-p920
    • Differentiated Thyroid Cancer: Onset and Outcome in a Pediatric Population with and without Risk Factors

      hrp0086p1-p921
    • Evaluation of the Usefulness of Serum Cytokines IL-1[beta] and sFasL Measurements in the Diagnosis of Autoimmune Hypothyroidism and Hyperthyroidism in Children

      hrp0086p1-p922
    • Small Thyroid Volume on Ultrasound in Infants with Transient TSH Elevation Following Referral by Newborn Screening

      hrp0086p1-p923
    • In Children with Autoimmune Thyroid Diseases the Association with Down syndrome can Modify the Clustering of Extra-Thyroidal Autoimmune Disorders

      hrp0086p1-p924
    • L-selenomethionine Supplementation in Children and Adolescents with Autoimmune Thyroiditis: Preliminary Results of a Randomized Double-blinded Placebo-controlled Clinical Trial

      hrp0086p1-p925
    • Minimally Invasive Video-Assisted Thyroid Surgery in Children: A Single Center Ten-Years Experience

      hrp0086p1-p926
    • Prevalence of Congenital Hypothyroidism and Thyroid Function Follow-Up of Children with Tsh Cutoff between 5 and 10 mIU/l in Neonatal Screening

      hrp0086p1-p927
    • Preliminary Results: Body Composition of Adolescent Patients with Congenital Hypothyroidism and Correlation with Laboratory Parameters

      hrp0086p1-p928
    • Neonatal Thyrotoxicosis and Craniosynostosis Associated with Maternal Graves' Disease and High Dose maternal Thyroxine Therapy for Papillary Carcinoma

      hrp0086p1-p929
    • Seasonality of Month of Birth in Children and Adolescents with Hashimoto Thyroiditis

      hrp0086p1-p930
    • Radioiodine Therapy for Graves' Disease - the Experience of a Portuguese Single Centre

      hrp0086p1-p931
  • Thyroid P2
  • • Multinodular Goiter and Differentiated Thyroid Cancer in Pediatrics

      hrp0086p2-p932
    • Clinical Case of Acute Liver Injury in Pediatric Patient with Autoimmune Hyperthyroidism

      hrp0086p2-p933
    • Thyroid Function in Children Affected By Congenital Hypothyroidism (CH) with Eutopic Thyroid After Discontinuation of Treatment with Levothyroxine

      hrp0086p2-p934
    • Hyperthyroidism in an Infant of a Mother with Autoimmune Hypothyroidism with Positive TSH Receptor Antibodies

      hrp0086p2-p935
    • Thyroid Cancer Presentation in Children is Different than in Young Adults

      hrp0086p2-p936
    • Starting Treatment in Congenital Hypothyroidism with Normal FT4 Levels and Thyroid Gland in situ Detected at Neonatal Screening

      hrp0086p2-p937
    • Distal Monosomy 10q Presented as Congenital Hypothyroidism

      hrp0086p2-p938
    • Five-Year Prospective Evaluation of Thyroid Function Test Evolution in Children with Hashimoto's Thyroiditis Presenting with Either Euthyroidism or Subclinical Hypothyroidism

      hrp0086p2-p939
    • An Unusual Case of Impaired Renal Function and Thrombocytopenia

      hrp0086p2-p940
    • Celiac Disease in Children and Adolescents with Hashimoto Thyroiditis

      hrp0086p2-p941
    • Euthyroid Hashimoto Thyroiditis in Children: Evolution Over Time

      hrp0086p2-p942
    • Thyrotoxic Periodic Paralysis, an Under-Recognized Condition

      hrp0086p2-p943
    • Age at Diagnosis and Mental Development in Children with Congenital Hypothyroidism in the Absence of Newborn Screening Programme

      hrp0086p2-p944
    • Vitamin D Levels in Children with Hashimoto's Thyroiditis: Before and after I-Thyroxine Therapy

      hrp0086p2-p945
    • The Aim of This Study was to Recognize Difference between Transient Congenital Hypothyroidism (TCH) from Permanent Congenital Hypothyroidism by Determining Clinical Characteristics, Laboratory Tests and Imaging Studies

      hrp0086p2-p946
    • Delayed Diagnosis of a TSH-Adenoma due to Coexisting Autoimmune Thyroid Disease

      hrp0086p2-p947
    • Kocher-Debre-Semelaigne Syndrome: Hypothyroidism with Muscle Pseudohypertrophy

      hrp0086p2-p948
    • Thyroid Function in Obese Children and Its Correlations with Chosen Atherogenic Risk Factors

      hrp0086p2-p949
    • The Evolution of Thyroid Function after Hashimoto's Thyroiditis Presentation is Different in Initially Euthyroid Girls with or without Turner Syndrome

      hrp0086p2-p950
    • Hashimoto's Thyroiditis in Childhood: An 8 Year Experience

      hrp0086p2-p951
    • Congenital Malformations, Dysmorphic Syndromes and Neurodevelopmental Problems in Children with Congenital Hypothyroidism

      hrp0086p2-p952
    • Clinical Value of Thyroid-Stimulating Immunoglobulin in Paediatric Autoimmune Thyroid Diseases

      hrp0086p2-p953
    • Hearing, Language and Communication Abilities in Children with Congenital Hypothyroidism

      hrp0086p2-p954
    • Lack of Catch Up Growth in Severe Hashimoto Thyroiditis (HT) in Young Children

      hrp0086p2-p955
    • Perinatal Factors Associated with Neonatal Thyroid Stimulating Hormone in Normal Newborns

      hrp0086p2-p956
    • TBG Excess as a Cause of Hyperthyroxinemia and High T3 Detected Incidentally or Through Neonatal Screening Test

      hrp0086p2-p957
    • Beta Thallassemia: The Relation between Ferritin and Hypothyroisdism and the Suppressing Effect of Ferritin on Autoimmune Disorders (a Hypothesis)

      hrp0086p2-p958
    • Thyroid Hormones and Risk Factors in Obese and Overweight Children

      hrp0086p2-p959
    • FNA: A Gold Standard in the Diagnosis of Thyroid Nodules in Children after Chemotherapy

      hrp0086p2-p960
    • Profound Growth Failure in Peripubertal Adolescents Presenting with Severe Acquired Autoimmune Hypothyroidism: A Case Series

      hrp0086p2-p961
    • Two Patients with Resistance to Thyroid Hormones

      hrp0086p2-p962
    • The Influence of Etiology and Treatment Factors on Intellectual Outcome in Congenital Hypothyroidism

      hrp0086p2-p963
    • An Unusual Complication of Graves' Disease

      hrp0086p2-p964
    • An Unusual form of Precocious Puberty: Van Wyk and Grumbach Syndrome

      hrp0086p2-p965
    • Clinical Features of Newborn with Congenital Hypothyroidism Diagnosed by Neonatal Screening: Single Center Experience

      hrp0086p2-p966
    • Postoperative Complications of Thyroidectomy in Children with Nodular Goiter

      hrp0086p2-p967
    • Peculiarities of Course and Therapy of Basedow-Graves' Disease in Children in Different Age Groups

      hrp0086p2-p968
    • An Unusual Presentation of Hashimoto Thyroiditis (HT) and Precocious Puberty: The Van Wyk-Grumbach Syndrome

      hrp0086p2-p969
    • Rare Case of Severe Hyperthyroidism due to Grave's Disease in a Female Toddler

      hrp0086p2-p970
    • Youngest Known Case of Autoimmune Thyroiditis Causing Hyperthyroidism in a Down's Syndrome Toddler

      hrp0086p2-p971
    • Thyroid Hormones in Obese Children

      hrp0086p2-p972
    • A Case of Neonatal Graves in a Premature Infant with Negative Thyroid Stimulating Immunoglobulins (TSI)

      hrp0086p2-p973
    • Severe Growth Retardation and Hypothyroidism due to Hashimoto's Thyroidits

      hrp0086p2-p974
    • Beta Thallassemia: the Relation between Ferritin and Hypothyroisdism and the Suppressing Effect of Ferritin on Autoimmune Disorders (a Hypothesis)

      hrp0086p2-p975
    • Severe Hyponatremia and Repeated Intestinal Resections for Intestinal Dysmotility Mimicking Congenital Aganglionic Megacolon due to Delay in the Diagnosis of Congenital Hypothyroidism

      hrp0086p2-p976
    • Very Early Onset of Autoimmune Thyroiditis in a Toddler with Multi-organ Involvement

      hrp0086p2-p977
    • A Case of the Thyroid Gland Dystopia in the Root of the Tongue

      hrp0086p2-p978
    • Conversion of Hypothyroidism to Hyperthyroidism in A Child with Down's Syndrome

      hrp0086p2-p979
    • Transient Congenital Hypothyroidism: About Six Cases

      hrp0086p2-p980
• Late Breaking
• • (1)
  • • 46,XY DSD due to Isolated AMH Deficiency Resulting in Persistent Mullerian Duct Syndrome (PMDS) as a Consequence of a Single-Base Deletion in a SF1-Response Element of the AMH promoter

      hrp0086lbp1
    • Sexual Outcomes in Brazilian Patients with 46,XY DSD

      hrp0086lbp2
    • The Growth Hormone - Insulin Like Growth Factor I (IGF-1) System in Early Non-Alcoholic Fatty Liver Disease: From an Animal Model to a Children's Cohort

      hrp0086lbp3
    • Sirolimus Precipitating Diabetes in a Patient with Congenital Hyperinsulinism due to Autosomal Dominant ABCC8 Mutation

      hrp0086lbp4
    • Development of Skeletal Microarchitecture and Biomechanics Over 2 Years Following 6 Month Intragastric Balloon Insertion in Obese Adolescents

      hrp0086lbp5
    • Children with Brain Tumors have Enhanced Visceral Adiposity Compared to Non-Cancer Controls: A Preliminary Analysis from the Canadian Study of Determinants of Endometabolic Health in Children Study

      hrp0086lbp6
    • Loss of Functional Osteoprotegerin: More than a Skeletal Problem

      hrp0086lbp7
    • Impact of Weight Loss after Bariatric Surgery on Gonadic Function in Severely Obese Female Adolescents

      hrp0086lbp8
    • Osteoprotegerin and Insulin Resistance in Childhood Obesity: A New Interplay?

      hrp0086lbp9
    • Molecular Analysis of AR, SRD5A2, NR5A1 and HSD17B3 Genes in a Brazilian 46,XY DSD Cohort

      hrp0086lbp10
    • Long-Term Safety and Effectiveness of Growth Hormone Treatment in Pediatric Patients with Growth Hormone Deficiency: Interim Results of LG Growth Study

      hrp0086lbp11
    • An Analysis of Symptoms and Signs of Adrenal Insufficiency in Children with CAH Admitted to Hospital in Australia

      hrp0086lbp12
    • Hyperprolactinemia in Children and Adolescents: A Review of Patients Presenting to a Tertiary Center in Australia

      hrp0086lbp13